2018 Annual Meeting | P5 - Poster Session V

Date Thursday 04/26/18

Time 11:30 AM - 07:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Global Health and Neuroepidemiology, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-rehabilitation, Research Methodology, ��ɫ��, and History

CME Available 0.00 credit

Event Timeline
11:30 AM - 07:00 PM	Abstract	001 - Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) Improves Parkinson's Disease (PD) Symptomatology Bryan Dobbs
11:30 AM - 07:00 PM	Abstract	002 - At-Home Tele-Monitored transcranial Direct Current Stimulation (tele-tDCS) Therapy for Fatigue in Parkinson's Disease Kush Sharma, MBBS
11:30 AM - 07:00 PM	Abstract	003 - Long term outcome from a randomized double-blind remotely supervised tDCS trial for symptomatic management in multiple sclerosis Michael Shaw
11:30 AM - 07:00 PM	Abstract	004 - Effects of Repetitive Transcranial Magnetic Stimulation in Aphasic Stroke: A Randomized Double-blind Controlled Clinical Trial. Federico Silva
11:30 AM - 07:00 PM	Abstract	005 - Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) is Feasible for 40 Treatment Sessions Bryan Dobbs
11:30 AM - 07:00 PM	Abstract	006 - Spinal cord epidural stimulation: classifying movement using accelerometers Nicholas E. Peterson
11:30 AM - 07:00 PM	Abstract	007 - Neofect Glove: Virtual Reality Device for Home Therapy in Stroke Survivors Alay Parikh
11:30 AM - 07:00 PM	Abstract	008 - The Holographic Electromyographic Automated Rehabilitation Technology (HEART) Project
11:30 AM - 07:00 PM	Abstract	009 - Cortical Somatosensory Responses after Botulinum Toxin Therapy of Post-Stroke Spasticity Petr Hlustik, MD, PhD
11:30 AM - 07:00 PM	Abstract	010 - Pooled Safety Analysis of Randomized, Prospective Studies on IncobotulinumtoxinA for the Treatment of Cervical Dystonia, Blepharospasm, and Upper Limb Spasticity David M. Simpson, MD, FAAN
11:30 AM - 07:00 PM	Abstract	011 - Physician's Global Assessment of Response to Repeated AbobotulinumtoxinA Injections in Adults with Lower Limb Spasticity Post-Stroke or Traumatic Brain Injury Alberto Esquenazi, MD
11:30 AM - 07:00 PM	Abstract	012 - Safety of IncobotulinumtoxinA in Adult Spasticity: Results from a Pooled Analysis of Randomized, Prospective, Clinical Studies David M. Simpson, MD, FAAN
11:30 AM - 07:00 PM	Abstract	013 - Effect on Voluntary Movements of Simultaneous Upper and Lower Limb AbobotulinumtoxinA Injections in Conjunction with Guided Self-Rehabilitation Contracts in Adults with Spastic Hemiparesis: Methodology of the ENGAGE Study
11:30 AM - 07:00 PM	Abstract	014 - Intrathecal Baclofen Therapy Decreases Pain and Improves Quality of Life Compared to Conventional Medical Management in Severe Post-Stroke Spasticity: the SISTERS Study Michael M. Yochelson, MD, FAAN
11:30 AM - 07:00 PM	Abstract	015 - Challenges and Strategies for Implementing Interventions in a Statewide System-Based Pragmatic Trial
11:30 AM - 07:00 PM	Abstract	016 - Modified Approach to Stroke Rehabilitation (MAStR)-Feasibility Study MaryKay A. Pavol, PhD
11:30 AM - 07:00 PM	Abstract	017 - Validation of the Spanish version of the CAL scale in stroke patients Maria Julieta Russo, MD
11:30 AM - 07:00 PM	Abstract	018 - Analysis of discharge functional outcomes & disposition locations following inpatient rehabilitation in Guillain-Barre Syndrome patients David S. Kushner, MD, FAAN
11:30 AM - 07:00 PM	Abstract	019 - A Predictive model for functional recovery of upper extremity after acute ischemic stroke
11:30 AM - 07:00 PM	Abstract	020 - The efficacy of acetylcholinesterase inhibitor on poststroke aphasia: a systemic review and meta-analayis of experimental studies Ian Shih, MD
11:30 AM - 07:00 PM	Abstract	021 - Anti-fibrotic approach and reactivation of neurogenesis by targeting the TGF-ß System Sabrina Kuespert, PhD
11:30 AM - 07:00 PM	Abstract	022 - Taking Steps Backward to Move Forward: A Preliminary Feasibility Study in Stroke Oluwole O. Awosika, MD, MSCR, FAAN
11:30 AM - 07:00 PM	Abstract	023 - Amelioration of left hand apraxia in a patient with callosal disconnection by use of mirror visual feedback therapy Riddhi Patira, MD
11:30 AM - 07:00 PM	Abstract	024 - Amantadine Use in Post-Concussive Headaches: An Exploratory Retrospective Review Conor Ryan, MD
11:30 AM - 07:00 PM	Abstract	025 - Compare serum Creatinine versus Renal 99mTc-DTPA scan determined Glomerular Filtration Rates in Veterans with Traumatic Spinal Cord Injury and Neurogenic bladder Meheroz H. Rabadi, MD, FAAN
11:30 AM - 07:00 PM	Abstract	026 - NA
11:30 AM - 07:00 PM	Abstract	027 - Ozanimod (RPC1063) Preserves Central Nervous System (CNS) Tissue in Rodents by Reducing Neuronal Breaks in Vivo and Modulating Astrocyte Activity in Vitro
11:30 AM - 07:00 PM	Abstract	028 - Multitasking is the Cognitive Ability Most Linked to Depression in Multiple Sclerosis Daniel P. Kurz, MD
11:30 AM - 07:00 PM	Abstract	029 - Aging is accelerating brain atrophy in MS patients Emanuele Ghione, MD
11:30 AM - 07:00 PM	Abstract	030 - Impacting The Natural History of Multiple Sclerosis: A Report on the First Generation of Treated Patients Thomas F. Scott, MD
11:30 AM - 07:00 PM	Abstract	031 - Alemtuzumab Reduced MRI Lesions and the Rate of Brain Volume Loss in CARE-MS II Patients Switching From SC IFNB-1a: 5-Year Follow-up (TOPAZ Study) Sven Schippling
11:30 AM - 07:00 PM	Abstract	032 - Disease activity during pregnancy after Fingolimod withdrawal due to planning a pregnancy in women with multiple sclerosis Spalmai M. Hemat
11:30 AM - 07:00 PM	Abstract	034 - Progressive Motor Impairment from a Critically Located Lesion in Highly Restricted CNS Demyelinating Disease Mark Keegan, MD, FAAN
11:30 AM - 07:00 PM	Abstract	035 - Astrocyte-T cell signaling via Junctional Adhesion Molecule-A (JAM-A) controls cytokine and protease secretion, T cell infiltration of the CNS and clinical disability during autoimmune attack Sam H. Horng, MD, PhD
11:30 AM - 07:00 PM	Abstract	036 - Serum and CSF Neuroflament Light Chain levels normalise following Bone Marrow Transplant in MS Patients Simon Thebault, MD
11:30 AM - 07:00 PM	Abstract	037 - Outcomes of Week-24 Completers and Subjects Who Had Follow-Up Beyond Week 24 After a Single Treatment of DaxibotulinumtoxinA for Injection (RT002): Results of a Phase 2, Open-Label (Level II), Dose Escalating Study in Isolated Cervical Dystonia Joseph Jankovic, MD, FAAN
11:30 AM - 07:00 PM	Abstract	038 - Golfer's Cramp: Quantitative Method for Separating Golfers with a Task-Specific Dystonia Charles H. Adler, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	039 - The Phenotype of ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP) is Broader than Previously Defined. Ihtsham Haq, MD, FAAN
11:30 AM - 07:00 PM	Abstract	040 - In Vivo RNA Transcriptional / Translational Landscape in X-linked Dystonia - Parkinsonism (XDP/DYT3) Patient-Specific Neuronal Cells Anna M. Szekely, MD
11:30 AM - 07:00 PM	Abstract	041 - Safety and Efficacy of IncobotulinumtoxinA for the Treatment of Blepharospasm in Botulinum Toxin-Naive Subjects Fernando L. Pagan, MD, FAAN
11:30 AM - 07:00 PM	Abstract	042 - Drivers of change in Toronto Western Spasmodic Rating Scale (TWSTRS) scores following botulinum toxin treatment: Impact of geographical region Carlo Colosimo, MD
11:30 AM - 07:00 PM	Abstract	043 - Assessment of non-motor symptoms and cognitive functions in patients with isolated adult-onset cervical dystonia previously not treated with botulinum toxin: a single-centre case-controled study Maja Relja, MD
11:30 AM - 07:00 PM	Abstract	044 - Validation of a Questionnaire for Distinguishing X-linked Dystonia Parkinsonism from XDP mimics Jose Danilo B. Diestro, MD
11:30 AM - 07:00 PM	Abstract	045 - Comparison of OnabotulinumtoxinA Utilization and Effectiveness Across Various Etiologies of Spasticity from the Adult Spasticity International Registry Study: ASPIRE
11:30 AM - 07:00 PM	Abstract	046 - Evolution of cervical dystonia patterns in subjects new to botulinum toxin treatment Richard M. Trosch, MD, FAAN
11:30 AM - 07:00 PM	Abstract	047 - Therapeutic benefits persist at the end of one botulinum toxin injection cycle in cervical dystonia - results from a meta-analysis of 1091 subjects Vivay Peter Misra, MD
11:30 AM - 07:00 PM	Abstract	048 - The Adult Spasticity International Registry (ASPIRE) Study: Real-World Treatment Utilization and Effectiveness of OnabotulinumtoxinA in Post-Stroke Patients Treated for Spasticity
11:30 AM - 07:00 PM	Abstract	049 - The Prevalence of Dystonic Tremor and Tremor Associated with Dystonia in Patients with Cervical Dystonia Lenka Hvizdosova
11:30 AM - 07:00 PM	Abstract	050 - Psychiatric Manifestations of Autosomal Dominant Dopa Responsive Dystonia Lindsey R. Neimand, MD
11:30 AM - 07:00 PM	Abstract	051 - Family structures in adult-onset focal Dystonia Maryamnaz Zaribaf, MD
11:30 AM - 07:00 PM	Abstract	052 - Cervical Dystonia Patients Treated with OnabotulinumtoxinA Report Improvements in Health-Related Quality of Life in a Multicentre, Prospective, Observational Study: POSTURe Marc Petitclerc, MD
11:30 AM - 07:00 PM	Abstract	053 - A case of levodopa responsive rapid onset dystonia-parkinsonism. Yeva M. Fernandez, MD
11:30 AM - 07:00 PM	Abstract	054 - Mingo Supplemental Trial: An Open-Label Prospective Randomized Controlled Trial in X-linked Dystonia Parkinsonism Patients in the Province of Capiz, Philippines Patrick Acuna
11:30 AM - 07:00 PM	Abstract	055 - Deep brain stimulation of the globus pallidus interna with microelectrode recording for Myoclonus-Dystonia (DYT-11): One year Outcome in Two Patients Murat Gultekin, MD
11:30 AM - 07:00 PM	Abstract	056 - Which factors predict patient satisfaction with botulinum toxin treatment for cervical dystonia in routine practice?
11:30 AM - 07:00 PM	Abstract	057 - Deep brain stimulation: a Treatment Modality for Generalized Dystonia Secondary to Anoxic Brain Injury in Adults Padmaja Vittal, MD, MS
11:30 AM - 07:00 PM	Abstract	058 - Evaluation of DTI-Tractography Findings in Botulinum Neurotoxin Injected Hemifacial Spasm Patients
11:30 AM - 07:00 PM	Abstract	059 - Early onset tremulous dystonia-a familial case and novel mutation Mariam a. Al Hussona, MB BCh BAO
11:30 AM - 07:00 PM	Abstract	060 - Body Region Response to Pallidal Deep Brain Stimulation in Isolated Dystonia Jennifer J. Choi, MD
11:30 AM - 07:00 PM	Abstract	061 - Cervical dystonia and substance abuse Abhimanyu Mahajan, MD, MHS, FAAN
11:30 AM - 07:00 PM	Abstract	062 - Focal Task-Specific Dystonia Affecting the Proximal Arm - An Under-Recognized Disorder? Christine Stahl, MD
11:30 AM - 07:00 PM	Abstract	063 - Acute and Reversible Sadness Following Deep Brain Stimulation Targeting the Globus Pallidus Internus in Dystonia
11:30 AM - 07:00 PM	Abstract	064 - Extended-release (ER) formulations of aminoadamantanes as NMDA-receptor antagonists: pharmacokinetic (PK) determinants of improved tolerability Jack Nguyen
11:30 AM - 07:00 PM	Abstract	065 - Pimavanserin use in a movement disorders clinic: a single center experience Abhimanyu Mahajan, MD, MHS, FAAN
11:30 AM - 07:00 PM	Abstract	066 - A Long-term Study on Effectiveness of Levodopa-carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease Patients Kallol R. Chaudhuri, MD, FRCP
11:30 AM - 07:00 PM	Abstract	067 - ITI-214, A Novel Phosphodiesterase Type I Inhibitor, For The Treatment Of Motor And Non-motor Symptoms Of Parkinson's Disease Robert Davis
11:30 AM - 07:00 PM	Abstract	068 - A Phase 2a study of nilotinib in patients with advanced and early Parkinson's disease. Study design Tanya Simuni, MD, FAAN
11:30 AM - 07:00 PM	Abstract	069 - Movement Disorder Specialists' Determination of Eligibility for Device Aided Treatment in Advanced Parkinson's Disease: Results from the OBSERVE-PD Study Alfonso Fasano, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	070 - Genomic analysis identifies new loci associated with motor complications in Parkinson's disease Sun Ju Chung, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	071 - Clinical Research Participation: Trials And Tribulations of The Limited English Proficiency Patient Volunteer in Parkinson`s Disease Clinical Trials. Pinky H. Agarwal, MD, FAAN
11:30 AM - 07:00 PM	Abstract	072 - Improvement in Attention/Memory Domains in Advanced Parkinson's Disease Patients Treated with Levodopa-carbidopa Intestinal Gel is Associated with Better Quality of Life David G. Standaert, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	073 - Barriers to Adherence to Physical Therapy, Occupational therapy, and Speech/Swallowing Therapy in Parkinson's Disease Gregory Vurture
11:30 AM - 07:00 PM	Abstract	074 - A Pilot Study on Dance/Movement Therapy in Parkinson's Disease Kristi Michels
11:30 AM - 07:00 PM	Abstract	075 - Effects of Rock Steady Boxing on Activities of Daily Living and Motor Symptoms of Parkinson's Disease Danielle Larson, MD
11:30 AM - 07:00 PM	Abstract	076 - Modulating BDNF Activity in Parkinson's Disease: the Impact of Aerobic Exercise and Transcranial Magnetic Stimulation
11:30 AM - 07:00 PM	Abstract	077 - Clinical and Genetic Evaluation of Spinocerebellar Ataxia Type 10
11:30 AM - 07:00 PM	Abstract	078 - Feasibility of Arterial Spin Labeling MR Imaging for Detecting Cerebellar Hypoperfusion in Patients with Spinocerebellar Degeneration Masamichi Ikawa
11:30 AM - 07:00 PM	Abstract	079 - Interplay of repeat expansion genes in spinocerebellar ataxia type 3
11:30 AM - 07:00 PM	Abstract	080 - Beyond Whole-Exome Sequencing: A Propos of Two Neurodegenerative Diseases. Fabio Nascimento, MD
11:30 AM - 07:00 PM	Abstract	081 - Ataxia with Oculomotor Apraxia 2 : Clinical and Genetic study of 17 patients
11:30 AM - 07:00 PM	Abstract	082 - Quality of Life in Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) Danielle N. Thordarson, MD
11:30 AM - 07:00 PM	Abstract	083 - NA
11:30 AM - 07:00 PM	Abstract	084 - NA
11:30 AM - 07:00 PM	Abstract	085 - Neurons on Wheels (NOW) - Bringing Neurologists Into Shelters for Better Patient Care Joy Z. Ding, MD
11:30 AM - 07:00 PM	Abstract	086 - Invasive Mucormycosis in an Immunocompetent Non-Diabetic with Severe Acidosis Akanksha Sharma, MD
11:30 AM - 07:00 PM	Abstract	087 - Polyarteritis Nodosa from Hepatitis B Infection Presenting with Bilateral Basal Ganglia Strokes and Sensorimotor Neuropathy Vincent Arnone, MD
11:30 AM - 07:00 PM	Abstract	088 - Epilepsy-related Injuries: A Case-control Study Mamta B. Singh, MD, MBBS, DM, FAAN
11:30 AM - 07:00 PM	Abstract	089 - Complete Neurologic Recovery after Acute Cauda Equina Syndrome due to Neuroschistosomiasis Paul M. Elsbernd, MD
11:30 AM - 07:00 PM	Abstract	090 - Gas-containing Cervical and Thoracic Spinal Epidural abscess secondary to Klebsiella Pneumonia infection Annie L. Hsieh, MD, PhD
11:30 AM - 07:00 PM	Abstract	091 - Safety and efficacy of fludrocortisone in treatment of cerebral salt wasting in tuberculous meningitis: a preliminary study Usha K. Misra, MD, FAAN
11:30 AM - 07:00 PM	Abstract	092 - Central Nervous System Manifestations of Mycoplasma Pneumoniae, Systematic Review of the Literature with Regard to Pathogenosis and Treatment in Adult Subjects, with First Case Report of Successful Treatment with Intravenous Immunoglobulin in an Adult Pirouz Piran, MD
11:30 AM - 07:00 PM	Abstract	093 - Neurocysticercosis: A Spanish center experience
11:30 AM - 07:00 PM	Abstract	094 - Central Nervous System Coccidioidomycosis: A descriptive 19-year experience at an endemic tertiary care center Erin M. Okazaki, MD
11:30 AM - 07:00 PM	Abstract	095 - Acute Flaccid Myelitis: Treatment Outcomes From a Tertiary Referral Center Benjamin M. Greenberg, MD, FAAN
11:30 AM - 07:00 PM	Abstract	096 - Is Infection at Stroke Onset Associated with Prognosis Following Acute Ischemic Stroke? Hamidreza Saber, MD
11:30 AM - 07:00 PM	Abstract	097 - Treatment practices and Persistent disease activity after 9 months of treatment in CNS tuberculosis- an ambispective cohort study
11:30 AM - 07:00 PM	Abstract	098 - Epidemiology, Outcomes and Prognosis of Central Nervous System Infections in Singapore - preliminary results from the Singapore Neurologic Infections Programme (SNIP) Kevin Tan, MD, FAAN
11:30 AM - 07:00 PM	Abstract	099 - Development of Transverse Myelitis after Vaccination, A CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Study, 1985-2017.
11:30 AM - 07:00 PM	Abstract	100 - Agitation in autoimmune and infectious encephalitis: a comparative study of clinical course and management at the neurological intensive care unit Johann Sellner, MD, FAAN
11:30 AM - 07:00 PM	Abstract	101 - Defining PML Spectrum Disease Lauren Reoma, MD, FAAN
11:30 AM - 07:00 PM	Abstract	102 - Clinical characteristics of HIV patients with acute stroke Hemil Gonzalez
11:30 AM - 07:00 PM	Abstract	103 - Neurosyphilis, Neither Gone Nor Forgotten: A Retrospective Study From Northeast México. Sergio A. Castillo-Torres, MD
11:30 AM - 07:00 PM	Abstract	104 - Clinical Features Of Seizures In Hiv Patients With Toxoplasma Encephalitis.
11:30 AM - 07:00 PM	Abstract	105 - Daclizumab, a Potential Exit Strategy in MS Patients at High Risk for Natalizumab-Associated PML? Tobias Moser
11:30 AM - 07:00 PM	Abstract	106 - A case of Listeria Rhombencephalitis: Emphasizing good outcome with awareness and prompt treatment.
11:30 AM - 07:00 PM	Abstract	107 - Elevated CSF 14- 3- 3 and Tau and Negative RT Quic after ECT Miriam L. Freimer, MD, FAAN
11:30 AM - 07:00 PM	Abstract	108 - Candida meningitis and ventriculitis after IV brown heroin use: a case series. Carolina VIVAR, MD
11:30 AM - 07:00 PM	Abstract	109 - Concurrent Faciobrachial Diplegia and Diaphragmatic Weakness Caused by Lyme Neuroborreliosis Ali Hejazi, MD, PhD
11:30 AM - 07:00 PM	Abstract	110 - MS and HIV: A case of MS-IRIS associated with antiretroviral therapy initiation Pria Anand, MD
11:30 AM - 07:00 PM	Abstract	111 - Subacute ZIKA Virus encephalitis in Rio de Janeiro. Joao Marcos C. Ferreira, Sr., MD
11:30 AM - 07:00 PM	Abstract	112 - Enteroviral T-Cell Encephalitis Related to Immnuosupresive Therapy Including Rituximab
11:30 AM - 07:00 PM	Abstract	113 - Central Nervous System Tuberculosis presenting as Acute Meningioencephalitis: A Case series describing an under recognized entity. Irfan A. Shah, MD
11:30 AM - 07:00 PM	Abstract	114 - Clinical Characteristics of Persistent/ Intractable Hiccups Caused by VZV Infection Nobuaki Yoshikura, MD, PhD
11:30 AM - 07:00 PM	Abstract	115 - Lyme Disease Presenting with Meningoradiculitis: A Case of Variant Bannwarth Syndrome Monica M. Diaz, MD, MS
11:30 AM - 07:00 PM	Abstract	116 - Palatal Tremor and Hypertrophic Olivary Degeneration after Listerial Rhombencephalitis Seong-il Oh
11:30 AM - 07:00 PM	Abstract	117 - IL6 and IL17 as inflammatory response in a case of Neurobrucellosis presenting as Leucoencephalopathy
11:30 AM - 07:00 PM	Abstract	118 - Bilateral Spontaneous Subdural Hematomas in an HIV Patient with A Normal Platelet Count Hisham G. Elkhider, MD
11:30 AM - 07:00 PM	Abstract	119 - HIV Related Opsoclonus-Mioclonus-Ataxia Syndrome As The Initial Neurological Presentation: A Case Report.
11:30 AM - 07:00 PM	Abstract	120 - A Rare Case of Neuroborreliosis Presenting with Intracranial Hypertension Anvi Gadani, MD
11:30 AM - 07:00 PM	Abstract	121 - Lemierre's Syndrome Complicated by Epidural Abscess Shoichi Shimamoto, MD
11:30 AM - 07:00 PM	Abstract	122 - Tuberculous myopathy
11:30 AM - 07:00 PM	Abstract	123 - Isolated abducens palsy from sinusitis related septic dural venous thrombosis invading Dorello's canal. Aparna Vaddiparti, MD
11:30 AM - 07:00 PM	Abstract	124 - Mysterious Meningitis: Recurrent chemical meningitis due to ruptured epidermoid cyst Bhavesh Trikamji, MD
11:30 AM - 07:00 PM	Abstract	125 - Streptococcus Pneumoniae Meningitis Presenting as Pseudo-subarachnoid Hemorrhage Jared M. Yee, MD
11:30 AM - 07:00 PM	Abstract	126 - A rare case of parainfectious brachial neuritis following Salmonella paratyphi bacteraemia Aravindhan Baheerathan, MBBS
11:30 AM - 07:00 PM	Abstract	127 - Starry Sky Image: Miliary Neurotuberculomas without apparent Pulmonary Injury Barbara F. Diniz, MD
11:30 AM - 07:00 PM	Abstract	128 - Paroxysmal Singultus as the result of Brainstem Histoplasmosis Nicholas Metrus, MD
11:30 AM - 07:00 PM	Abstract	129 - The Danger of Flying with Acute Otitis Media, Which May Result in Gradenigo's Syndrome Lauren L. Spiegel, MD
11:30 AM - 07:00 PM	Abstract	130 - Vision impairment and papilledema as the initial manifestation of neurosyphilis in a young immunocompetent patient Doyle Yuan, MD
11:30 AM - 07:00 PM	Abstract	131 - Atypical Presentation of Probable Creutzfeldt-Jakob Disease Associated with Anti-Zic4 Antibody: Literature Review of Neuronal Antibodies in Creutzfeldt-Jakob Disease Richard Salazar, MD, FAAN
11:30 AM - 07:00 PM	Abstract	132 - Longitudinally Extensive Spinal Arachnoid Cyst Secondary to Chronic Coccidioides immitis Meningitis Tyler Koehn, MD
11:30 AM - 07:00 PM	Abstract	133 - Atypical presentation of Cytomegalovirus meningoencephalitis in a immunocompetent patient
11:30 AM - 07:00 PM	Abstract	134 - An interesting case of Nocardial brain abscess mimicking brain tumor in an immunocompetent patient. Aiga Rakhesh, MD
11:30 AM - 07:00 PM	Abstract	135 - Acute Streptococcal pneumoniae Meningoencephalitis Associated with a Multitude of Vascular Complications Sara Dawit, MD
11:30 AM - 07:00 PM	Abstract	136 - A New Tick Palsy: Case of Guillian-Barre Syndrome Associated with Lyme Disease Mena Samaan, MD
11:30 AM - 07:00 PM	Abstract	137 - Myoclonic jerks as a unique clinical manifestation in a patient with Murine Typhus Ahmad Yusuf Solaiman, MD
11:30 AM - 07:00 PM	Abstract	138 - A severe case of Cytomegalovirus (CMV) meningoencephalitis in an otherwise healthy immunocompetent 2 month old male. Whitney Gervelis, DO
11:30 AM - 07:00 PM	Abstract	139 - Optic Neuritis and Hemiparesis in a Previously Healthy Young Woman Dulanji Kuruppu, MD
11:30 AM - 07:00 PM	Abstract	140 - A Rare Case of Creutzfeldt-Jakob Disease with Elevated Anti-Thyroid Antibodies Subhendu Rath, MBBS
11:30 AM - 07:00 PM	Abstract	141 - An Intriguing Case of Unresolved Post-Operative Pneumocephalus Ylec M. Cardenas Castillo, MD
11:30 AM - 07:00 PM	Abstract	142 - Neurosyphilis Mimicking Sarcoidosis with CNS Involvement. Okkes Kuybu, MD
11:30 AM - 07:00 PM	Abstract	143 - Cerebral Histoplasmosis: Relate of Case. Nayme H. Monfredini
11:30 AM - 07:00 PM	Abstract	144 - Brain Heme Oxygenase Antioxidant and Type I Interferon Responses in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques: A Model for Human Brain Responses to HIV Maria E. Diaz Ortiz, MD, PhD
11:30 AM - 07:00 PM	Abstract	145 - MRI Brain Abnormalities in Acute Flaccid Myelitis: Characteristics and Differentiation from Acute Disseminated Encephalomyelitis Sarah Hopkins, MD
11:30 AM - 07:00 PM	Abstract	146 - Chronic Exposure to West Nile Virus Leads to Neuroinvasive-Like Syndrome in Mice Parminder Vig, PhD
11:30 AM - 07:00 PM	Abstract	147 - Florence Foster Jenkins and Neurosyphilis in the 1940s J. David Avila, MD, FAAN
11:30 AM - 07:00 PM	Abstract	148 - HIV and Alzheimer's Disease: Tat, Beta-Amyloid, and Neprilysin
11:30 AM - 07:00 PM	Abstract	149 - Image studies in Zika Virus neurological complications Pedro H. Macedo, Sr., MD
11:30 AM - 07:00 PM	Abstract	150 - Tubercular Meningitis - Clinical profile and Validation of Thwaites Diagnostic Criteria. Sankar P. Gorthi, MD, FAAN
11:30 AM - 07:00 PM	Abstract	151 - Evaluation of Adenosine Deaminase activity in CSF for diagnosis of Tuberculous Meningitis Abul K. Shoab, MD, FAAN
11:30 AM - 07:00 PM	Abstract	152 - Viral encephalitis: What are the most common viruses in patient admitted to an University Hospital in the Tropics? Karylsa L. Torres Gomez, MD
11:30 AM - 07:00 PM	Abstract	154 - The International HIV Dementia Scale as a screening tool for HAND in Uganda Maria E. Molinaro, MD
11:30 AM - 07:00 PM	Abstract	155 - Etiologies and Outcomes among Non-Traumatic Spinal Cord Injuries in Uganda Kisekka A. Musubire, MBBS
11:30 AM - 07:00 PM	Abstract	156 - The Spectrum of Neurological Disorders at an Outpatient Clinic in Addis Ababa, Ethiopia Mehila Z. Wuhib, MD
11:30 AM - 07:00 PM	Abstract	157 - Head CT Findings at a Public Hospital in Rural Haiti: Retrospective Analysis of 3614 CT Scans Ioannis K. Valtis
11:30 AM - 07:00 PM	Abstract	158 - Etiology and clinical profiles of pediatric encephalitis in Myanmar: A prospective study Alyssa Smith, MD
11:30 AM - 07:00 PM	Abstract	159 - Perception of Functioning as a Potential Screening Modality for HIV-Associated Neurocognitive Disorder in Nigeria Deidre Ammah, MD
11:30 AM - 07:00 PM	Abstract	160 - Perinatal Case Fatality Rate in Cases of Congenital Zika Syndrome: a Cross-Sectional Study
11:30 AM - 07:00 PM	Abstract	161 - Developing a Child Neurology Training Program in Cambodia: A Pilot Study Brian G. Wong, MD
11:30 AM - 07:00 PM	Abstract	162 - Telemedicine as a pivotal part of rural neurology and migraine management. Nawaz Hack, MD
11:30 AM - 07:00 PM	Abstract	163 - Using Social Media to Enhance Neurology ��ɫ�� and Engagement During Short-Term Global Health Initiatives Brian G. Wong, MD
11:30 AM - 07:00 PM	Abstract	164 - A Spatial Analysis of Amyotrophic Lateral Sclerosis (ALS) Cases in the United States and their Proximity to Multidisciplinary ALS Clinics, 2013
11:30 AM - 07:00 PM	Abstract	165 - Association of Lead Exposure on Cognitive Decline due to Mediation and Interaction with Uric Acid Vy T. Nguyen
11:30 AM - 07:00 PM	Abstract	166 - Pre-diagnostic branched chain amino acids and the risk of ALS Kjetil Bjornevik, MD, PhD
11:30 AM - 07:00 PM	Abstract	167 - Are ALS Motor Phenotypes stochastic? Adriano Chio, MD, FAAN
11:30 AM - 07:00 PM	Abstract	168 - Evaluating the completeness of the National ALS Registry, United States Wendy E. Kaye, PhD
11:30 AM - 07:00 PM	Abstract	169 - NA
11:30 AM - 07:00 PM	Abstract	170 - NA
11:30 AM - 07:00 PM	Abstract	171 - NA
11:30 AM - 07:00 PM	Abstract	172 - NA
11:30 AM - 07:00 PM	Abstract	173 - Machine-driven Classification of Cognitive Profiles Jordan Weiss
11:30 AM - 07:00 PM	Abstract	174 - The Correlation Between Reported Changes in Cognitive Functioning and Objective Performance on Cognitive Screening in English- and Spanish-speaking Patients Reena Gottesman, MD
11:30 AM - 07:00 PM	Abstract	175 - Sleep Patterns In Patients At Risk For Alzheimer's Disease May Be Related To Cognitive Performance and Amyloid Burden Peter Z. Yan, MD, MS
11:30 AM - 07:00 PM	Abstract	176 - In-vivo mapping of monoaminergic network disruption in Alzheimer's disease: implications for neuropsychiatric symptoms
11:30 AM - 07:00 PM	Abstract	177 - Alzheimer Signature of Cortical Thinning Associated with Poorer Cognitive Performance Regardless of Amyloid Burden in Normal Elderly Catherine Veilleux
11:30 AM - 07:00 PM	Abstract	178 - The relationship between Mini-Mental State Examination (MMSE) & Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) using real world data in US & Europe Rezaul Khandker
11:30 AM - 07:00 PM	Abstract	179 - Picture Memory Impairment Screen: Montefiore-Einstein Center for the Aging Brain Experience Reena Gottesman, MD
11:30 AM - 07:00 PM	Abstract	180 - Identifying Cognitive Subtypes of Mild-to-Moderate Alzheimer's Disease Using the National Alzheimer's Coordinating Center Uniform Dataset Neuropsychological Test Battery Yuqi Qiu
11:30 AM - 07:00 PM	Abstract	181 - Measuring Sentence Production in Primary Progressive Aphasia Elisa Canu
11:30 AM - 07:00 PM	Abstract	182 - Effects of Age on the Spanish English Neuropsychological Assessment Scale in Normal Elderly and Autosomal Dominant Alzheimer's disease John M. Ringman, MD, FAAN
11:30 AM - 07:00 PM	Abstract	183 - Performance on the Cognitive Abilities Screening Instrument (CASI) among Spanish and English Speakers at-risk for Autosomal Dominant Alzheimer's Disease
11:30 AM - 07:00 PM	Abstract	184 - Cognitive Functions After Serial CSF Tap Test In Probable and Possible Idiopathic Normal Pressure Hydrocephalus.
11:30 AM - 07:00 PM	Abstract	185 - Visual Association Test: A brief cognitive tool and low cost alternative to biomarkers in predicting progression of amnestic mild cognitive impairment to Alzheimer's disease Ratnavalli Ellajosyula, MD, DM, FAAN
11:30 AM - 07:00 PM	Abstract	186 - The Cortical Lesion Pattern Of Dysexecutive Syndrome in MEMENTO cohort Daniela Andriuta
11:30 AM - 07:00 PM	Abstract	187 - Trajectory and Variability Characterization of the Montreal Cognitive Assessment in Older Adults Edward Y. Zamrini, MD
11:30 AM - 07:00 PM	Abstract	188 - Validation of a Pre-Diagnostic Progression Rate Used to Predict Post-Diagnostic Change on Common Alzheimer's Disease Outcome Measures Valory Pavlik, PhD
11:30 AM - 07:00 PM	Abstract	189 - Line Bisection and Trisection, Age and Accuracy
11:30 AM - 07:00 PM	Abstract	190 - Capturing Latency in Cognitive Symptoms for People with Significant Memory Concern
11:30 AM - 07:00 PM	Abstract	191 - Discriminability index as a possible measure of Alzheimer's disease progression validated using the Alzheimer's Disease Neuroimaging Initiative database Maria Julieta Russo, MD
11:30 AM - 07:00 PM	Abstract	192 - Trajectory of Memory Decline Differs in Hippocampal Sclerosis and Alzheimer's Disease Denis Smirnov
11:30 AM - 07:00 PM	Abstract	193 - Simulation study on differences in Alzheimer Disease (AD) Cooperative Study-Preclinical Alzheimer Cognitive Composite (ADCS-PACC) Based on Long-term Clinical Outcomes Anuraag Kansal
11:30 AM - 07:00 PM	Abstract	194 - Neuropsychology, Criminalization in Frontotemporal Syndromes and Impaired Sense of Agency Michael Hoffmann, MD, FCP, FAHA, FAAN
11:30 AM - 07:00 PM	Abstract	195 - Cholinergic modulation targeting medial prefrontal cortex leads to behavior deficit in interval timing task Qiang J. Zhang, MD
11:30 AM - 07:00 PM	Abstract	196 - Depression, Fatigue, and Their Association with Post-Stroke Disability Lucy Tan
11:30 AM - 07:00 PM	Abstract	197 - Cognitive Change in Cognitively Intact Amyotrophic Lateral Sclerosis: Reliable Change Index in a population-based cohort.
11:30 AM - 07:00 PM	Abstract	198 - Longitudinal Predictors of Caregiver Burden in Amyotrophic Lateral Sclerosis: A population-based cohort of cognitively intact patient-caregiver dyads.
11:30 AM - 07:00 PM	Abstract	199 - Opportunities for Improved End-of-Life Care in Dementia with Lewy Bodies: Survey Results Melissa Armstrong, MD, MSc, FAAN, FAAN
11:30 AM - 07:00 PM	Abstract	200 - Protocolizing Work-up for Normal Pressure Hydrocephalus Improves Evaluation and Outcomes Lealani M. Acosta, MD, MPH, FAAN
11:30 AM - 07:00 PM	Abstract	201 - Prognostic Markers and Outcome of Decompressive Hemicraniectomy in Malignant Middle Cerebral Artery Infarction Kaushik Gowthaman, Jr., MD
11:30 AM - 07:00 PM	Abstract	202 - Combined Antagonism of Vasopressin Receptor Subtypes with Conivaptan Attenuates Cerebral Edema Following Ischemic Stroke Saeed Ansari, MD
11:30 AM - 07:00 PM	Abstract	203 - Does 24-hour CT Scan Post Thrombolysis Change Management in Acute Ischemic Stroke Patients? Syed F. Ali, MD
11:30 AM - 07:00 PM	Abstract	204 - Twelve versus twenty four hour bed rest after acute ischemic stroke reperfusion therapy Brian Silver, MD, FAAN
11:30 AM - 07:00 PM	Abstract	205 - Association between timing of direct enteral tube placement and outcomes after acute stroke Raed Joundi, MD, PhD
11:30 AM - 07:00 PM	Abstract	206 - Neurology Inpatient Services Saves Lives and Money Ajal Dave, MD
11:30 AM - 07:00 PM	Abstract	207 - Variability in Inpatient Acute Ischemic Stroke Diagnostic Evaluation and Secondary Prevention at Acute Stroke Ready Hospitals Andrew J. Zhang, MD
11:30 AM - 07:00 PM	Abstract	208 - Adherence to the Clinical Practice Guidelines of the Stroke Society of the Philippines in the Management of Ischemic Stroke in young adults admitted in 3 tertiary hospitals in Bacolod City, Philippines from May to October 2010 Beverly B. Baliguas, MD
11:30 AM - 07:00 PM	Abstract	209 - Comparison of Length of Stay and Discharge Disposition between Anticoagulants for Secondary Stroke Prevention in Atrial Fibrillation Sanskriti Mishra, MD
11:30 AM - 07:00 PM	Abstract	210 - Early Initiation of Direct-acting Oral Anticoagulants after Cardioembolic Stroke or TIA is Safe and Effective Win Toe, MD
11:30 AM - 07:00 PM	Abstract	211 - Prevalence of Microembolic Signals in Patients with Cerebral Ischemic Events Arth K. Srivastava, MD
11:30 AM - 07:00 PM	Abstract	212 - Early Neurological Deterioration in Patients with Large Vessel Occlusion Hazem M. Shoirah, MD
11:30 AM - 07:00 PM	Abstract	213 - Optimal Systolic Blood Pressure Goals after Successful Mechanical Thrombectomy for Patients with Large Vessel Occlusion Strokes Ovais Inamullah, MD
11:30 AM - 07:00 PM	Abstract	214 - Power Motion Mode Transcranial Doppler examination in Posterior Circulation Strokes
11:30 AM - 07:00 PM	Abstract	215 - Utility of transcranial Doppler(TCD) in the treatment and diagnosis Of Vertebral Basilar Insufficiency(VBI) Richard D. Serano, MD
11:30 AM - 07:00 PM	Abstract	216 - Outcome of Basilar Artery Occlusion in Urban and Rural Centers: Analysis of a National Cross-Sectional Database Piotr Bzdyra, MD
11:30 AM - 07:00 PM	Abstract	217 - Carotid Artery Web Causing Recurrent Middle Cerebral Artery Acute Ischemic Strokes in a Young Patient Sishir Mannava, MD
11:30 AM - 07:00 PM	Abstract	218 - Large Artery Atherosclerosis Modifies the Relationship between Kidney Function and Cerebral Small Vessel Disease Dong-Hui Ao
11:30 AM - 07:00 PM	Abstract	219 - Transthyretin levels negatively correlate with carotid carotid intima-media thickness and beta-stiffness index.
11:30 AM - 07:00 PM	Abstract	220 - Carotid artery stenosis is uncommon as a cause of stroke in Saudi population Misealreem Shaheen
11:30 AM - 07:00 PM	Abstract	221 - Extracranial and Intracranial Non-Stenotic Carotid Atherosclerotic Plaques in ESUS Patients Rajasumi Rajalingam
11:30 AM - 07:00 PM	Abstract	222 - Clinico-vascular Correlation In Carotid Stroke Pratheep Kumar S, MD
11:30 AM - 07:00 PM	Abstract	223 - Prevalence and Outcomes of Intracranial Hemodynamic Steal in Symptomatic Internal Carotid Artery Occlusions Mukesh Kumar
11:30 AM - 07:00 PM	Abstract	224 - Uric Acid Predicts Carotid Plaque Stability, Cerebrovascular Events, Cardiovascular Events and Death in Patients Undergoing Carotid Endarterectomy
11:30 AM - 07:00 PM	Abstract	225 - High-Sensitive C-Reactive Protein Predicts Cerebrovascular and Cardiovascular Events in Patients Undergoing Carotid Endarterectomy
11:30 AM - 07:00 PM	Abstract	226 - Non Invasive Imaging of Vulnerable Plaques: An Institutional Experience Lakshmi N. Ranganathan, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	227 - Geometric characteristics of Middle Cerebral Artery Atherosclerosis and Clinical Stroke: An Observational Study Yannan Yu, MD
11:30 AM - 07:00 PM	Abstract	228 - Enlarged Perivascular Spaces in the Basal Ganglia are Independently Associated with Intracranial Atherosclerosis in the Elderly. Victor J. Del Brutto, MD
11:30 AM - 07:00 PM	Abstract	229 - Factors Associated with Short-term Outcome in Patients with Symptomatic Severe Middle Cerebral Artery Stem Stenosis
11:30 AM - 07:00 PM	Abstract	230 - Stroke recurrence in symptomatic intracranial atherosclerotic disease in Southern Brazil Marcos C. Lange, MD
11:30 AM - 07:00 PM	Abstract	231 - The Association between Arterial Tortuosity and Ischemic Stroke in Intracranial Atherosclerotic Disease Dong-Ick Shin, MD, PhD
11:30 AM - 07:00 PM	Abstract	232 - Extracranial carotid atherosclerotic disease in context of middle cerebral artery stenosis Nada A. Elsaid
11:30 AM - 07:00 PM	Abstract	233 - Vertebral Artery Origin Stent Placement Using the Dual Lumen Qureshi-Jiao Guidecatheter Hamza I. Maqsood, MD
11:30 AM - 07:00 PM	Abstract	234 - Electronic Decision Support for Improvement of Contemporary Therapy for Stroke prevention (EDICTS) Seemant Chaturvedi, MD, FAHA, FAAN
11:30 AM - 07:00 PM	Abstract	235 - Cerebral Microbleeds in a Stroke Prevention Clinic A-Hyun Cho, MD, PhD
11:30 AM - 07:00 PM	Abstract	236 - Tracking the Development of Risk Factors for Cerebrovascular Disease After Pregnancy with Preeclampsia Shambaditya Das, Jr., MD, MBBS
11:30 AM - 07:00 PM	Abstract	237 - Does maternal age impact development of vascular risk factors following preeclampsia? Desiree Nguyen
11:30 AM - 07:00 PM	Abstract	238 - Use of Vascular Preventative Medications in Patients with OSA Sarah Marmol, MD
11:30 AM - 07:00 PM	Abstract	239 - Generic Clopidogrel: Has Substitution for Brand Name Plavix® Been Safe and Effective? Francis M. Gengo, PharmD
11:30 AM - 07:00 PM	Abstract	240 - Antiplatelet Therapy as Primary Prevention for Patients with Type 2 Diabetes Mellitus: A Population-Based Study in Taiwan Yen-chung Chen, MD
11:30 AM - 07:00 PM	Abstract	241 - TIA-Minor Stroke Outpatient Pathway-Safety Implementation Study (TOP-SAILS) Lauren E. Dunn, MD
11:30 AM - 07:00 PM	Abstract	242 - Expansion of the Rapid-Access Transient Ischemic Attack (TIA) Clinic Referrals from Emergency Department to Primary Care: Improving outcomes and reducing costs Sarah Hermanson, DNP, ARNP
11:30 AM - 07:00 PM	Abstract	243 - Use of a Transient Ischemic Attack (TIA) center decreased length of stay for ischemic stroke and TIA patients in a primary stroke center Claire E. Carrazco, DO
11:30 AM - 07:00 PM	Abstract	244 - Creation of a Dedicated Neurovascular Discharge Follow-Up Clinic in Assessing Its Effect on 30 Day Readmission Rates: A Quality Improvement Initiative Elizabeth M. Aradine, MD
11:30 AM - 07:00 PM	Abstract	245 - Quality Improvement: Improving Primary Care Follow-Up for Stroke/TIA Patients Muhammad O. Salim Khan, DO
11:30 AM - 07:00 PM	Abstract	246 - Predictors of Non-adherence to Post-Stroke Hospitalization Clinic Follow-Up Carolina Temple
11:30 AM - 07:00 PM	Abstract	247 - The association of office-based provider visits with emergency department utilization among publicly insured stroke survivors.
11:30 AM - 07:00 PM	Abstract	248 - "Inflammatory Cerebral Amyloid Angiopathy: Approach to Clinical Diagnosis" Grace Crotty, MD
11:30 AM - 07:00 PM	Abstract	249 - Predictors of good functional outcome in patients treated with intravenous thrombolysis via telestroke. Tarun Girotra, MD
11:30 AM - 07:00 PM	Abstract	250 - Observational study of a regional inter-hospital telestroke network in the thrombectomy era Ricardo Varela, MD
11:30 AM - 07:00 PM	Abstract	251 - Demographics and Outcomes Between Telestroke and Routine Hospital Transfers in Acute Ischemic Stroke Aashrai S. Gudlavalleti, MBBS
11:30 AM - 07:00 PM	Abstract	252 - Single-Center Retrospective Comparison of Prehospital Large Vessel Occlusion Tools David M. Ermak, DO
11:30 AM - 07:00 PM	Abstract	253 - Assessing Accuracy in Nurse Activated Stroke Codes in the Emergency Department Kristin L. Miller, MD
11:30 AM - 07:00 PM	Abstract	254 - Effective Endovascular Routing within Stroke Systems of Care Angela M. Hawkins, RN
11:30 AM - 07:00 PM	Abstract	255 - Stroke Related ��ɫ�� To Emergency Department (ED) Staff - An Acute Stroke Care Quality Improvement Initiative Rohit Bhatia, MD, MBBS, DM
11:30 AM - 07:00 PM	Abstract	256 - How experts diagnose TIA: A systematic review Tess Fitzpatrick, MD
11:30 AM - 07:00 PM	Abstract	257 - NA
11:30 AM - 07:00 PM	Abstract	258 - NA
11:30 AM - 07:00 PM	Abstract	259 - Racial Influence on Antiepileptic Drug levels Advait Mahulikar, MD
11:30 AM - 07:00 PM	Abstract	260 - Tolerability and efficacy of adjunctive lacosamide in children and adolescents with focal seizures in context of presence or absence of sodium-channel blocking AEDs: Post-hoc analysis of a randomized, double-blind, placebo-controlled trial Ingrid E. Scheffer, MBBS, PhD, FRACP, AO
11:30 AM - 07:00 PM	Abstract	261 - Hallucinations as Adverse Event from Lacosamide: Three Case Series Alok Patel, MD
11:30 AM - 07:00 PM	Abstract	262 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of TAK-935 in Healthy Subjects
11:30 AM - 07:00 PM	Abstract	263 - Evaluation of pharmacodynamic effects of cholesterol 24-hydroxylase inhibitor TAK-935 and its target engagement in animals Tatsuki Koike
11:30 AM - 07:00 PM	Abstract	264 - Inhibition of Cholesterol 24-hydroxylase is a Novel Pharmacological Strategy for Epilepsy Treatment
11:30 AM - 07:00 PM	Abstract	265 - Clinical Trial Simulations for Paediatric Dose Selection Using a Pharmacokinetic/Enzyme-Occupancy/Pharmacodynamic Model of TAK-935, a Cholesterol 24S-hydroxylase Inhibitor
11:30 AM - 07:00 PM	Abstract	266 - A Phase 1b/2a Study to Examine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-935 as an Adjunctive Therapy in Subjects with Developmental and/or Epileptic Encephalopathies
11:30 AM - 07:00 PM	Abstract	267 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of TAK-935 in Healthy Subjects Grace G. Cheng, MD, PhD
11:30 AM - 07:00 PM	Abstract	268 - Analysis of Sodium Levels and Hyponatremia Events in Trials of Eslicarbazepine Acetate (ESL) in Pediatric Patients (Aged 4-17 years) Inna I. Vaisleib, MD
11:30 AM - 07:00 PM	Abstract	269 - Safety and Tolerability of Adjunctive Eslicarbazepine Acetate (ESL) in Pediatric Patients (Aged 4-17 Years) with Partial-Onset (Focal) Seizures (POS) Mark Mintz, MD, FAAN
11:30 AM - 07:00 PM	Abstract	270 - Analysis of Psychiatric Treatment-Emergent Adverse Events (TEAEs) in Two Phase III Conversion-to-Eslicarbazepine Acetate (ESL) Monotherapy Trials Cynthia L. Harden, MD
11:30 AM - 07:00 PM	Abstract	271 - Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use Eugen Trinka
11:30 AM - 07:00 PM	Abstract	272 - Incidence of Treatment-Emergent Adverse Events (TEAEs) According to Baseline Antiepileptic Drug (AED) Use: A Pooled Analysis of Data from Phase II/III Trials of Adjunctive Eslicarbazepine Acetate (ESL) in Children Elaine C. Wirrell, MD, FAAN
11:30 AM - 07:00 PM	Abstract	273 - An Analysis of the Accuracy and Utility of Automated Kit (AK) Assays in Quantifying Thyroid Hormone Levels in Patients Taking Eslicarbazepine Acetate (ESL)
11:30 AM - 07:00 PM	Abstract	274 - Evaluation of the Impact of Potential Missing Seizure-diary Data on Primary Efficacy Outcomes in Phase III Studies of Adjunctive Eslicarbazepine Acetate (ESL) for Partial-onset (Focal) Seizures Hailong Cheng
11:30 AM - 07:00 PM	Abstract	275 - Determination of the Minimal Clinically Important Difference (MCID) in Seizure Frequency in Three Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL) for Partial-onset (Focal) Seizures (POS) Hailong Cheng
11:30 AM - 07:00 PM	Abstract	276 - An Analysis of the Efficacy and Tolerability of Eslicarbazepine Acetate (ESL) by Study Period in Two Phase III Conversion-to-ESL Monotherapy Trials Steve Chung, MD, FAAN
11:30 AM - 07:00 PM	Abstract	277 - Analysis of Cognitive Adverse Events in Two Phase III Conversion-to-Eslicarbazepine Acetate (ESL) Monotherapy Trials Jay Salpekar
11:30 AM - 07:00 PM	Abstract	278 - Mechanism of Action of Cenobamate: Preferential Inhibition of the Persistent Sodium Current
11:30 AM - 07:00 PM	Abstract	279 - Cenobamate (YKP3089) in Photosensitive Patients: Proof of Principle
11:30 AM - 07:00 PM	Abstract	280 - Pharmacokinetics of Cenobamate (YKP3089): Results From Single and Multiple Oral Rising-Dose Studies in Healthy Subjects Laurent Vernillet
11:30 AM - 07:00 PM	Abstract	281 - CX-8998, a potent, selective T-type calcium channel antagonist dose-dependently suppresses seizures in the WAG/Rij genetic model of absence epilepsy. Margaret S. Lee, PhD
11:30 AM - 07:00 PM	Abstract	282 - A Phase 2a Study of CX-8998, an Oral, Potent and Selective T-Type Calcium Modulator in Adolescents and Young Adults with Absence Epilepsy: Rationale for population and dose selection Spyridon Papapetropoulos, MD, PhD
11:30 AM - 07:00 PM	Abstract	283 - Anti-Epileptic Monotherapy for Elderly Patients with New-Onset Seizures, a Meta-Analysis Bahar S. Malakouti, MD
11:30 AM - 07:00 PM	Abstract	284 - Effect of Endovascular Treatment On Post Stroke Seizures. Jaysingh Singh, MD
11:30 AM - 07:00 PM	Abstract	285 - Serial non-adherence in epilepsy clinics: an analysis of patient characteristics and resource utilization. Huan G. Huynh, MD
11:30 AM - 07:00 PM	Abstract	286 - Incidence of EEG seizures in patients with intraparenchymal hemorrhage re-veals a significant role for subcortical hemorrhages in epileptogenicity. Prachi T. Parikh, MD
11:30 AM - 07:00 PM	Abstract	287 - Refractory Epilepsy Screening Tool for Lennox-Gastaut Syndrome (REST-LGS): Improving the Detection of LGS in the Clinic Steven M. Wolf, MD
11:30 AM - 07:00 PM	Abstract	288 - Clobazam Effect on Seizure Control and Quality of life in children with refractory epilepsy Leon A. Weinstock, MD
11:30 AM - 07:00 PM	Abstract	289 - Efficacy and Tolerability of Intravenous Levetiracetam as Monotherapy in Acute Seizure Management in Children Donald C. Barr, MD
11:30 AM - 07:00 PM	Abstract	290 - Mapping Musical Automatism: Further insights from Epileptic High-Frequency Oscillations Analysis James F. Rini, MD
11:30 AM - 07:00 PM	Abstract	291 - Epilepsy After Stroke
11:30 AM - 07:00 PM	Abstract	292 - NA
11:30 AM - 07:00 PM	Abstract	293 - NA
11:30 AM - 07:00 PM	Abstract	294 - NA
11:30 AM - 07:00 PM	Abstract	295 - History of Key Developments that Led to Nerve Conduction Studies in Human Subjects Edward J. Fine, MD, FAAN
11:30 AM - 07:00 PM	Abstract	296 - The many faces of apomorphine: lessons from the past and challenges for the future
11:30 AM - 07:00 PM	Abstract	297 - Kabbalah and the Frontal Lobe Jeffrey M. Kornitzer, MD, FAAN
11:30 AM - 07:00 PM	Abstract	298 - The Life of Solomon Carter Fuller: An African American Pioneer in Neurology Ogechukwu Nwanegwo
11:30 AM - 07:00 PM	Abstract	299 - Brief History of Electrical Cortical Stimulation: A Journey in time from Volta to Penfield Cigdem Isitan-Alkawadri, MD
11:30 AM - 07:00 PM	Abstract	300 - Neurology and the First Ladies Teryn Nogles, MD
11:30 AM - 07:00 PM	Abstract	301 - The Contribution of Medieval Islamic Scholars to the Progress of Neuroscience; Headache
11:30 AM - 07:00 PM	Abstract	302 - The Influence of Neurology and Neurologists in the Women's Suffrage Movement Eric S. Farbman, MD, FAAN
11:30 AM - 07:00 PM	Abstract	303 - Babinski's Mexican Lost Legacy: The Case of Antonio A. Loaeza (1871-1947) Guillermo R. Delgado-Garcia, MD, MSc
11:30 AM - 07:00 PM	Abstract	304 - Milestones of spinal imaging: myelography in the pre-MRI era Peter Bede, MD, PhD
11:30 AM - 07:00 PM	Abstract	305 - The Split between Neurology and Psychiatry: Historical Overview Mohamed Kazamel, MD
11:30 AM - 07:00 PM	Abstract	306 - Enjolras Vampré: a pioneer of Clinical Neurology in South America Roberto Prado, MD, PhD
11:30 AM - 07:00 PM	Abstract	307 - Parkinsonian Advices or on a nowadays little read essay of James P. of Hoxton Square, Shoreditch, London. Ylmar Correa Neto, MD
11:30 AM - 07:00 PM	Abstract	309 - Jean-Martin Charcot's influence on Sigmund Freud's career
11:30 AM - 07:00 PM	Abstract	310 - Neurological References in Ernst Cassirer's The Phenomenology of Knowledge (1929) Guillermo R. Delgado-Garcia, MD, MSc
11:30 AM - 07:00 PM	Abstract	311 - REQUIEM FOR A NEUROLOGIST: THE FUNERAL RITES OF JEAN-MARTIN CHARCOT.
11:30 AM - 07:00 PM	Abstract	312 - The American Civil War and the Birth of American Neurology Scott Rewinkel, MD
11:30 AM - 07:00 PM	Abstract	313 - Imaginary Neuroscience in Georges Perec's Cantatrix sopranica L. (1974) Guillermo R. Delgado-Garcia, MD, MSc
11:30 AM - 07:00 PM	Abstract	314 - Between Weir Mitchell and Autoimmunity: Donato Alarcón-Segovia's Contribution to the Study of Erythromelalgia Guillermo R. Delgado-Garcia, MD, MSc
11:30 AM - 07:00 PM	Abstract	315 - A Brief History of Mindfulness for Application in Neurology and for Prevention of Burnout. Sankar Bandyopadhyay, MD, FAAN
11:30 AM - 07:00 PM	Abstract	316 - Neurophysiological Dreams in Georges Perec's La Boutique obscure (1973) Guillermo R. Delgado-Garcia, MD, MSc
11:30 AM - 07:00 PM	Abstract	317 - Disease of Drivers Contributing to Incidence of Fatal Crashes: A Responsibility Analysis Study Byungkwan Hwang, MD, PhD
11:30 AM - 07:00 PM	Abstract	318 - Dry beriberi: a still existent and treatable condition in Western world. Andrea Loggini, MD, MPH MBA
11:30 AM - 07:00 PM	Abstract	319 - Hawkes Sign: A Novel Office Test for Carpal Tunnel Syndrome Christopher H. Hawkes, MD, Bsc, FRCP, FAAN
11:30 AM - 07:00 PM	Abstract	320 - The role of Vitamin D in treatment of Chronic Insomnia with Melatonin Greta Sahakyan, MD
11:30 AM - 07:00 PM	Abstract	321 - Electrophysiological and LANSS Pain Scale Score Relationship in Patients with Carpal Tunnel Syndrome Krishnamoorthy Kuppusamy, Jr., MD
11:30 AM - 07:00 PM	Abstract	322 - Mercurial Channel Disease - A New Entity Balasubramanian Samivel, MD
11:30 AM - 07:00 PM	Abstract	323 - Brain Plasticity after Spinal Cord Decompression in Cervical Spondylotic Myelopathy Patients Depends on Corticospinal Tract Integrity Pavel Hok, MD
11:30 AM - 07:00 PM	Abstract	324 - Serum Vitamin B12 Levels in Subacute Combined Degeneration Tracey H. Fan, DO
11:30 AM - 07:00 PM	Abstract	325 - Persistent Postural-Perceptual Dizziness (PPPD) and TBI
11:30 AM - 07:00 PM	Abstract	326 - The Effects of Venlafaxine vs Gabapeptine in Fibromyalgia
11:30 AM - 07:00 PM	Abstract	327 - Post hoc analysis using PRO-ACT database to evaluate Repository Corticotropin Injection (H.P. Acthar® Gel) as a potential treatment for ALS Susan Vanmeter, MD
11:30 AM - 07:00 PM	Abstract	328 - Neurological complications after liver transplant: a not only frequent but also disturbingly heterogeneous phenomenon. Guido D. Vazquez II, PhD
11:30 AM - 07:00 PM	Abstract	329 - What do we think patients know about cannabis in neurological diseases?
11:30 AM - 07:00 PM	Abstract	330 - Preliminary findings of a prospective study: pre and post liver transplant evaluation of neurological complications and its clinical-neurocognitive-imaging correlate
11:30 AM - 07:00 PM	Abstract	331 - Rationale and Design for a Multicenter, Double-blind, Placebo-Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects with Amyotrophic Lateral Sclerosis Susan Vanmeter, MD
11:30 AM - 07:00 PM	Abstract	333 - Double Dorsiflexion Sign (DDFS) and Double Finger Tap Sign (DFTS): More tricks in the neurologist's bag for assessing non-physiological weakness? Reema Choudhry, MD
11:30 AM - 07:00 PM	Abstract	334 - Time Course of Onset of Phantom Pain in Male and Female Amputees Talal Aboud, MD
11:30 AM - 07:00 PM	Abstract	335 - Comparison of Metabolic Profiles of Newer Second Generation Antipsychotics Traci Aladeen, PharmD
11:30 AM - 07:00 PM	Abstract	336 - Massive Ballooning of redundant myelin sheaths in DS
11:30 AM - 07:00 PM	Abstract	337 - L-Methylfolate Calcium in Adolescents and Children: A Retrospective Analysis Michelle Rainka, PharmD
11:30 AM - 07:00 PM	Abstract	338 - NA
11:30 AM - 07:00 PM	Abstract	339 - JC Virus Granule Cell Neuronopathy as a Manifestation of the Immune Reconstitution Syndrome in Human Immunodeficiency Virus. Khalil Husari, MD
11:30 AM - 07:00 PM	Abstract	340 - A Rare Case of Herpes Simplex Virus Type 2 Encephalitis in an Immunocompetent Adult Melissa Cook, MD
11:30 AM - 07:00 PM	Abstract	341 - Syndromic categorization of acute central nervous system infections may help clinicians rationalize use of neuroimaging Kevin Tan, MD, FAAN
11:30 AM - 07:00 PM	Abstract	342 - A rare case of pertussis encephalopathy in an immunocompetent adult
11:30 AM - 07:00 PM	Abstract	343 - Peripheral Neuropathies in a Tropical Country: an Image Approach
11:30 AM - 07:00 PM	Abstract	344 - Of Competence and Compromise: Developing Standards in the Treatment of Chronic Cryptococcal Meningitis in Non-HIV-Infected Patients Satabdi Chakrabarti Pulakanti, DO
11:30 AM - 07:00 PM	Abstract	345 - Real-world Strategies for Management of Gastrointestinal Events in Patients Treated with Delayed-release Dimethyl Fumarate: EFFECT Gastrointestinal Sub-study Results Jinny Min
11:30 AM - 07:00 PM	Abstract	346 - Can Personalized Natalizumab Dosing Mitigate PML Risk and Minimize Disease Breakthrough? A Novel Assessment of Active Unbound Natalizumab John F. Foley, MD, FAAN
11:30 AM - 07:00 PM	Abstract	347 - Patient initiation of fingolimod treatment: comparison of cardiac monitoring in-clinic and in the Gilenya@Home program John Osborne
11:30 AM - 07:00 PM	Abstract	348 - Relapses during high doses of biotin in progressive multiple sclerosis: A case series Pierre Branger
11:30 AM - 07:00 PM	Abstract	349 - The Middle Cerebellar Peduncle Lesion in Natalizumab-Treated Multiple Sclerosis Patients: Think Twice Before Assuming a Relapse Ahmed Z. Obeidat, MD, PhD
11:30 AM - 07:00 PM	Abstract	350 - Autoimmune Hepatitis During Treatment of Multiple Sclerosis with Alemtuzumab Aaron M. Carlson, MD
11:30 AM - 07:00 PM	Abstract	351 - Selective and Discontinuous Reduction of B and T Lymphocytes and NK Cells in Patients with Early and Relapsing MS (ORACLE-MS, CLARITY and CLARITY Extension) after Administration of Cladribine Tablets Olaf Stuve, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	352 - A Case of Severe Legionella Pneumonia following the Second Treatment Course of Alemtuzumab Infusion for Relapsing Remitting Multiple Sclerosis Elizabeth Spurgeon, MD
11:30 AM - 07:00 PM	Abstract	353 - Fatal leukoencephalopathy in a patient with multiple sclerosis following treatment with ocrelizumab Robert Kadish, MD
11:30 AM - 07:00 PM	Abstract	354 - Neutropenia Following Treatment with Rituximab for Multiple Sclerosis Lindsay A. Horton, MD
11:30 AM - 07:00 PM	Abstract	355 - Delayed Onset of CD8+ T cell Leukoencephalitis After Bone Marrow Transplantation Erin Balcom, MD
11:30 AM - 07:00 PM	Abstract	356 - Impact of disease-modifying treatments on the longitudinal evolution of anti-JCV antibody index in multiple sclerosis Harald Hegen, MD
11:30 AM - 07:00 PM	Abstract	357 - Limited Impact of Long-term Teriflunomide Treatment on Lymphocyte Counts and Infection Rates in the Pooled TEMSO and TOWER Core and Extension Trials Aaron E. Miller, MD, FAAN
11:30 AM - 07:00 PM	Abstract	359 - Successful treatment of multi-drug resistant primary CNS vasculitis with natalizumab Paula Hardeman
11:30 AM - 07:00 PM	Abstract	360 - Six year prospective immunological study of Alemtuzumab treated patients: focus on CD4+ T cell subsets Marinella Clerico, MD
11:30 AM - 07:00 PM	Abstract	361 - Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry
11:30 AM - 07:00 PM	Abstract	362 - Clinical Trial and Post-marketing Reports Indicate No Increased Risk of Herpes Zoster in Patients Treated With Delayed-release Dimethyl Fumarate Jerome Hanna
11:30 AM - 07:00 PM	Abstract	363 - Generation and Analysis of Human T Cell Lines Responsive to Glatiramer Acetate
11:30 AM - 07:00 PM	Abstract	364 - Long-term Lymphocyte Counts in Patients with RRMS Treated with Cladribine Tablets 3.5 mg/kg: Total Lymphocytes, B-, and T-cell Subsets
11:30 AM - 07:00 PM	Abstract	365 - Memory B Cells: Toward a Unified Therapeutic Target for Effective Immunotherapy in Multiple Sclerosis Bryan Ceronie, MBBS
11:30 AM - 07:00 PM	Abstract	366 - Lymphocyte Decline and Reconstitution After Discontinuation in Patients With Severe, Prolonged Lymphopenia Treated With Delayed-Release Dimethyl Fumarate Robert J. Fox, MD, FAAN
11:30 AM - 07:00 PM	Abstract	367 - Safety of Alemtuzumab After Exposure to Chemotherapeutic Agents in Patients with Multiple Sclerosis - Experience of a single MS center Daniela A. Pimentel Maldonado, MD, MSCR
11:30 AM - 07:00 PM	Abstract	368 - Development of Tumefactive MS Lesions in association with Fingolimod: a case series Erica H. Parrotta, DO
11:30 AM - 07:00 PM	Abstract	369 - Impact of Immunodepleting Treatment with Alemtuzumab on the Peripheral Treg Compartment in Patients with Multiple Sclerosis
11:30 AM - 07:00 PM	Abstract	370 - Effectiveness of Lymphocyte-based Re-treatment Criteria in Minimizing the Incidence of Severe Sustained Lymphopenia during Treatment with Cladribine Tablets 3.5mg/kg Stuart D. Cook, MD, FAAN
11:30 AM - 07:00 PM	Abstract	371 - Rebound of disease activity after fingolimod (FTY) withdrawal: can we predict it? Julio Dotor Garcia-Soto
11:30 AM - 07:00 PM	Abstract	372 - Screening patients for their immunization status when transitioning to B-cell depleting therapy Lakshman N. Arcot Jayagopal, MD
11:30 AM - 07:00 PM	Abstract	373 - Herpes reactivation after Fingolimod in MS patients: What happens after drug use in real world? Talyta Grippe, MD
11:30 AM - 07:00 PM	Abstract	374 - A Case of Progressive Multifocal Leukoencephalopathy in a Patient on Extended Interval Dose Natalizumab Josef M. Gutman, MD
11:30 AM - 07:00 PM	Abstract	375 - Lymphomatoid Papulosis in a 37-year-old Woman with Relapsing Multiple Sclerosis Treated with Dimethyl Fumarate Ilena George, MD
11:30 AM - 07:00 PM	Abstract	376 - Lymphocyte Counts in Patients Treated With Teriflunomide: Observations From Phase 3 Clinical Trials and the Real-World Teri-PRO Study Patricia K. Coyle, MD, FAAN
11:30 AM - 07:00 PM	Abstract	377 - Lack of Lymphopenia Following First Phase of Treatment with Alemtuzumab Joshua Stone, MD
11:30 AM - 07:00 PM	Abstract	378 - A longitudinal study of JC virus serostatus stability among Multiple Sclerosis Patients Raed Alroughani, MD, FAAN
11:30 AM - 07:00 PM	Abstract	379 - Does early tonsillectomy decrease the risk of infection with JC virus. Mirla L. Avila, MD, FAAN
11:30 AM - 07:00 PM	Abstract	380 - Treatment of natalizumab-induced PML with cidofovir or CMX001 (brincidofovir) and mirtazapine Svetlana Eckert, MD
11:30 AM - 07:00 PM	Abstract	381 - Two Sides of the NMDA Receptor Autoimmune Encephalitis Spectrum: the Tip of the Iceberg? Mayra Montalvo Perero, MD
11:30 AM - 07:00 PM	Abstract	382 - Post-Transplant Autoimmune Encephalitis Devon Cohen, MD
11:30 AM - 07:00 PM	Abstract	383 - NINJA; Normal-appearing Imaging-associated, Neuroimmunologically Justified, Autoimmune Encephalomyelitis Daiki Takewaki
11:30 AM - 07:00 PM	Abstract	384 - Chronic Antibody-Negative Autoimmune Limbic Encephalitis: A Case Report Trenton J. Tollefson, MD
11:30 AM - 07:00 PM	Abstract	385 - Anti-NMDAR Encephalities: A Report of Eight Cases Tsubasa Yuki
11:30 AM - 07:00 PM	Abstract	386 - AMPA-R Limbic Encephalitis associated with Systemic Lupus Erythematosus: a case report Zoya Zaeem, MD
11:30 AM - 07:00 PM	Abstract	387 - Clinical presentation and treatment of autoimmune encephalitis: single center cohort study of 47 cases. Muhammad Affan, MD
11:30 AM - 07:00 PM	Abstract	388 - Assessing neurological disease in patients with common variable immunodeficiency Jonathan R. Galli, MD
11:30 AM - 07:00 PM	Abstract	389 - GFAP antibody mediated autoimmune meningo-encephalomyelitis - first reported fatal outcome in a healthy young patient Raquel Fonseca, MD
11:30 AM - 07:00 PM	Abstract	390 - Clinical findings, IgG subclass, and antibody effects in encephalitis associated with metabotropic glutamate receptor 5 (mGluR5) antibodies Marianna Spatola, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	391 - A rare case of anti-NMDAR encephalitis complicating pregnancy Sabrina Kalam, BM
11:30 AM - 07:00 PM	Abstract	392 - Effect of Rituximab on Seizure Burden in Patients with Rasmussen Encephalitis: A Case Series Rachelle Herring, MD
11:30 AM - 07:00 PM	Abstract	393 - A bout of confusion: Atypical presentations of Anti-Leucine-rich-Glioma-Inactivated 1(LGI -1) encephalitis - an emerging cause of limbic encephalitis (LE) Karan K. Topiwala, MBBS
11:30 AM - 07:00 PM	Abstract	394 - An Unusual Presentation of Anti-NMDA Receptor Antibody Positive Encephalitis: Non-Epileptic Spells and A Splenial Lesion on Brain MRI Alison L. Christy, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	395 - Nivolumab Induced Auto-immune Encephalitis Nidaullah Mian, MD
11:30 AM - 07:00 PM	Abstract	396 - A rare cause of limbic encephalitis Mario Sousa, MD
11:30 AM - 07:00 PM	Abstract	397 - N-Type Calcium Channel Antibody Encephalitis Coexisting With Multiple Sclerosis Michael V. Robers, MD
11:30 AM - 07:00 PM	Abstract	398 - A Fatal Case of Adult-Onset Acute Necrotizing Encephalitis Secondary to Influenza A Virus Varun C. Pulakanti, MD
11:30 AM - 07:00 PM	Abstract	399 - Comparison of Costs and Outcomes of Patients Presenting with a Rare Brainstem Syndrome Devin E. Prior, MD
11:30 AM - 07:00 PM	Abstract	400 - A spectrum of autoimmune encephalitis: a realistic and challenging diagnosis Joao Marcos C. Ferreira, Sr., MD
11:30 AM - 07:00 PM	Abstract	401 - The Incidence and Prevalence of Autoimmune Encephalitis and a comparison to Infectious Encephalitis: A Population-Based Study Divyanshu Dubey, MD, FAAN
11:30 AM - 07:00 PM	Abstract	402 - Unique FDG-PET findings in anti-LGI-1 encephalitis Jennifer Lyons, MD
11:30 AM - 07:00 PM	Abstract	403 - Brain FDG-PET in assessment of autoimmune encephalopathies Tarun Singhal, MD
11:30 AM - 07:00 PM	Abstract	404 - Anti-GAD-65 associated Progressive Encephalomyelitis with Rigidity and Myoclonus following West Nile Virus Encephalitis. Jordan S. Loeb, DO
11:30 AM - 07:00 PM	Abstract	405 - An Institutional Analysis of Serum and CSF Autoantibodies to Aid in the Diagnosis of Limbic Encephalitis George W. Culler IV, MD
11:30 AM - 07:00 PM	Abstract	406 - Unsual Case of Methadone Induced Toxic Leukoencephalopathy Sharjeel Panjwani, MD
11:30 AM - 07:00 PM	Abstract	407 - Defining the Clinical Spectrum of Variant-Stiff Person Syndrome: a Case Series Thomas J. Shoemaker, MD
11:30 AM - 07:00 PM	Abstract	408 - Neurological Paraneoplastic Autoimmunity and Small-Cell Lung Cancer: Clinical and Serological Accompaniments Anastasia Zekeridou, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	409 - Anti-CRMP5-Associated Paraneoplastic Neurologic Syndrome Developing in a Patient with Metastatic Merkel Cell Carcinoma During Immune Checkpoint Inhibitor Treatment Bianca Santomasso, MD
11:30 AM - 07:00 PM	Abstract	410 - Could neurological involvement in Behçet’s Disease occur atypically? Aksel Siva, MD
11:30 AM - 07:00 PM	Abstract	411 - Neuro-Sweet's Syndrome, a Diagnostic Conundrum Kanita Beba Abadal, MD
11:30 AM - 07:00 PM	Abstract	412 - Hypocupremia induced Encephalomyelopathy with CSF Oligoclonal Bands Anastasie M. Dunn-Pirio, MD
11:30 AM - 07:00 PM	Abstract	413 - Ipilimumab Induced Auto-immune Hypophysitis Nidaullah Mian, MD
11:30 AM - 07:00 PM	Abstract	414 - Improvement of Stiff Person Syndrome Symptoms During Pregnancy Megan E. Esch, MD
11:30 AM - 07:00 PM	Abstract	415 - A Case of Posterior Predominant Leucoencephalopathy Secondary to Vitamin B12 Deficiency David P. Vaughan, MBBS
11:30 AM - 07:00 PM	Abstract	416 - Case Report: Hypertrophic Pachymeningitis (HP) from IgG4-RD (related disease - A rare presentation or its most common cause? Karan K. Topiwala, MBBS
11:30 AM - 07:00 PM	Abstract	417 - Corpus Callosum lesions as diagnostic keys for differentiating Susac Syndrome and primary angiitis of central nervous system Mariano Marrodan, MD
11:30 AM - 07:00 PM	Abstract	418 - Bagel Sign in neuro-Behςet's Syndrome Ugur Uygunoglu
11:30 AM - 07:00 PM	Abstract	419 - Glial fibrillary acidic protein (GFAP) autoimmunity in the setting of seropositive rheumatoid arthritis treated with etanercept Kelsey M. Smith, MD
11:30 AM - 07:00 PM	Abstract	420 - Clinical Episode of Aseptic Meningitis with Leptomeningeal Enhancement in Patient with Anti-MOG Antibodies Sasmit Sarangi, MD, MBBS
11:30 AM - 07:00 PM	Abstract	421 - Meningioma Mimicry: Biopsy confirmed neurosarcoidosis presenting as multiple extra axial intracranial masses Mark-Victor Siwoski, MD
11:30 AM - 07:00 PM	Abstract	422 - Aseptic Meningitis as a Manifestation of the Anti-MOG Syndrome Adrian Hadiono, MD
11:30 AM - 07:00 PM	Abstract	423 - Acute Hemorrhagic Leukoencephalitis (AHLE): A Case Report With a Successful Outcome Wejdan Balubaid, MBBS
11:30 AM - 07:00 PM	Abstract	424 - Clinical and Immunological Investigation of Anti-Glutamic Acid Decarboxylase 65 Antibodies in Suspected Neurological Autoimmunity Lei Liu, MD, PhD
11:30 AM - 07:00 PM	Abstract	425 - Routine Laboratory Measures in the Controlled-Treatment Period of Phase III Ocrelizumab Trials in Relapsing and Progressive Multiple Sclerosis Jerry S. Wolinsky, MD, FAAN
11:30 AM - 07:00 PM	Abstract	426 - Rationale and Design of the Traditional versus Early Aggressive Therapy for MS (TREAT-MS) Trial Scott D. Newsome, DO, FAAN
11:30 AM - 07:00 PM	Abstract	428 - RITUXIMAB AS RESCUE THERAPY IN RRMS PATIENTS WITH DISEASE ACTIVITY DESPITE SECOND-LINE TREATMENT Pierre Durozard
11:30 AM - 07:00 PM	Abstract	429 - Examining longitudinal functional changes in Dysferlinopathy: The JAIN Clinical Outcome Study Linda P. Lowes, PT PhD
11:30 AM - 07:00 PM	Abstract	430 - Development of PPMO for the Treatment of Duchenne Muscular Dystrophy Marco Passini
11:30 AM - 07:00 PM	Abstract	431 - A randomized, placebo-controlled, double-blind, Phase 1b/2 study of the novel anti-myostatin adnectin RG6206 (BMS-986089) in ambulatory boys with Duchenne muscular dystrophy Kathryn R. Wagner, MD, PhD
11:30 AM - 07:00 PM	Abstract	432 - Impact on respiratory decline resulting from idebenone treatment in patients with Duchenne muscular dystrophy (DMD): Results of Meta-analysis
11:30 AM - 07:00 PM	Abstract	433 - Longitudinal Evaluation of Disease Progression in Congenital Myotonic Dystrophy Nicholas E. Johnson, MD, FAAN
11:30 AM - 07:00 PM	Abstract	434 - Effects of Weakness of Orofacial Muscles on Swallowing and Communication in Facioscapulohumeral Muscular Dystrophy
11:30 AM - 07:00 PM	Abstract	435 - Motor Unit Control in Myotonic Dystrophy Type 1 Trevor Moravec, MD
11:30 AM - 07:00 PM	Abstract	436 - Impact of Idebenone on rate of respiratory function decline in Duchenne muscular dystrophy (DMD)
11:30 AM - 07:00 PM	Abstract	437 - Neurodevelopmental needs in young boys with Duchenne Muscular Dystrophy: Observations from the CINRG DMD Natural History Study Mathula Thangarajh, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	438 - Self-Reported Sleep Features in Myotonic Dystrophies
11:30 AM - 07:00 PM	Abstract	439 - An Interactive Telephone-Based Patient-Reported Electronic Diary in Myotonic Dystrophy Type 1 Jeffrey Statland, MD
11:30 AM - 07:00 PM	Abstract	440 - A Novel Genotype and Pathological Phenotype in a Patient with Myosin Heavy Chain 2A Myopathy Nicolas Madigan, MD
11:30 AM - 07:00 PM	Abstract	441 - Dysmetria in Myotonic Dystrophy type 1 S H. Subramony, MBBS, FAAN
11:30 AM - 07:00 PM	Abstract	442 - Effects of MNK-1411 on Inflammation and Muscle Function in the mdx Mouse Model Dale Wright
11:30 AM - 07:00 PM	Abstract	443 - Investigation of Ranolazine as an Anti-myotonia Treatment in Myotonic Dystrophy Type 1
11:30 AM - 07:00 PM	Abstract	444 - Electromechanical Delay During Goal-directed Movements in Myotonic Dystrophy type 1 (DM 1) S H. Subramony, MBBS, FAAN
11:30 AM - 07:00 PM	Abstract	445 - Limb-girdle muscular dystrophy 1D including a novel p.Phe100Ile (c.298T < A) mutation in DNAJB6 in three Koreans from two families Woo-kyung Kim, MD
11:30 AM - 07:00 PM	Abstract	446 - Phenotypic Heterogeneity in Limb-girdle Muscular Dystrophy Type 2L (Anoctaminopathy) Kamal Shouman, MD
11:30 AM - 07:00 PM	Abstract	447 - Accuracy of Online Diagnostic Assistants for Diagnosing Limb Girdle Muscular Dystrophies Hamza T. Malek, MD
11:30 AM - 07:00 PM	Abstract	448 - Rhabdomyolysis and Fluctuating Asymptomatic HyperCKemia Associated with CACNA1S Variant Charenya Anandan, MD
11:30 AM - 07:00 PM	Abstract	449 - Limb-girdle muscular dystrophy type 2L - A case series from a tertiary center Ricardo Varela, MD
11:30 AM - 07:00 PM	Abstract	450 - Limb-Girdle Muscular Dystrophy: A Perspective from Patients on What Matters Most Michael C. Hunter, MD
11:30 AM - 07:00 PM	Abstract	451 - Cardioembolic stroke in a 23-year-old man with elbow contracture, an unusual presentation of Emery Dreifuss Muscular Dystrophy (EDMD) Bhaskar Roy, MD, FAAN
11:30 AM - 07:00 PM	Abstract	452 - Clinical, pathological and molecular characterization of a Limb-girdle muscular dystrophy type 2I(LGMD-2I) cohort Mario Sousa, MD
11:30 AM - 07:00 PM	Abstract	453 - Cumulative Motor Index (CMI) in Duchenne Muscular Dystrophy (DMD) Jenny Lin, MD
11:30 AM - 07:00 PM	Abstract	454 - Phenotypic and muscle biopsy features of patients with FKRP c.1387A>G founder mutation Angela Lee
11:30 AM - 07:00 PM	Abstract	455 - Muscle Strength and Function Measures in a Multicenter Study of Myotonic Dystrophy Type 1 (DM1): Baseline Impairment and Test-Retest Agreement over 3 Months Katy Eichinger, PhD, PT, DPT, NCS
11:30 AM - 07:00 PM	Abstract	456 - Diagnostic Yield of a Next Generation Sequencing Panel for Muscular Dystrophies and Hereditary Myopathies in Southern Brazil Pablo B. Winckler, MD, PhD
11:30 AM - 07:00 PM	Abstract	457 - Case report: Hereditary myopathy with early respiratory failure and ventricular tachycardia Emily R. Grodinsky, MD
11:30 AM - 07:00 PM	Abstract	458 - A Novel Mutation in Acid Alpha Glucosidase resulting in Late-Onset Pompe Disease Eric Libell, MD
11:30 AM - 07:00 PM	Abstract	459 - Efficacy and Safety of Valproic Acid for Spinal Muscular Atrophy: a Systematic Review and Meta-analysis. Mohamed Fahmy Doheim
11:30 AM - 07:00 PM	Abstract	460 - Positive cytosolic 5-nucleotidase 1A antibodies in motor neuron disorders Rami-james K. Assadi, MD
11:30 AM - 07:00 PM	Abstract	461 - Guaiacol can be a drug-candidate for treating Adult Polyglucosan Body Disease Or Kakhlon, PhD
11:30 AM - 07:00 PM	Abstract	462 - Longitudinal Clinical Assessment in Stiff Person Syndrome: Evidence of a Progressive and Disabling Disorder Goran Rakocevic, MD, FAAN
11:30 AM - 07:00 PM	Abstract	463 - Unrecognized Respiratory Manifestations of Stiff Person Syndrome (SPS) Anthony T. Allen II, MD
11:30 AM - 07:00 PM	Abstract	464 - Urinary and Bowel Symptoms in Adult Patients with Adrenoleukodystrophy
11:45 AM - 11:50 AM	Discussion	P5.027
11:50 AM - 11:55 AM	Discussion	P5.028
11:55 AM - 12:00 PM	Discussion	P5.029
12:00 PM - 12:05 PM	Discussion	P5.030
12:05 PM - 12:10 PM	Discussion	P5.031
12:10 PM - 12:15 PM	Discussion	P5.032
12:15 PM - 12:20 PM	Discussion	P5.033
12:20 PM - 12:25 PM	Discussion	P5.034
12:25 PM - 12:30 PM	Discussion	P5.035
12:30 PM - 12:35 PM	Discussion	P5.036
05:30 PM - 07:00 PM	Discussion	Poster Author Standby Time

Faculty Disclosures
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
John W. Day, MD, PhD	Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PepGen. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epirium Bio. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Astellas Pharma. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. The institution of Dr. Day has received research support from AMO Pharma. The institution of Dr. Day has received research support from AnnJi. Dr. Day has received research support from CureSMA. The institution of Dr. Day has received research support from Muscular Dystrophy Association. The institution of Dr. Day has received research support from Ionis Pharmaceuticals. The institution of Dr. Day has received research support from NMD Pharma. The institution of Dr. Day has received research support from SMA Foundation. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Aaron E. Miller, MD, FAAN	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Jennifer Lyons, MD	Dr. Lyons has received personal compensation for serving as an employee of Biogen. Dr. Lyons has received stock or an ownership interest from Biogen.
	No disclosure on file
Madhu Soni, MD, FAAN	Dr. Soni has received personal compensation in the range of $500-$4,999 for serving as a Physician Lead (Honorarium) in Women Leading in Neurology Program with ��ɫ��.
Gavin Giovannoni, MD	Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Shah A. Syed, MD	No disclosure on file
Troy Desai, MD	Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Desai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Desai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech.
Ana-Claire L. Meyer, MD, FAAN	Dr. Meyer has received personal compensation for serving as an employee of Denali Therapeutics.
Andrew McKeon, MD	The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Petr Kanovsky, PhD	Dr. Kanovsky has nothing to disclose.
Freddi I. Segal-Gidan, PhD, PA	No disclosure on file
Nicholas E. Johnson, MD, FAAN	Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Johnson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Evolyra Therapeutics . Dr. Johnson has stock in Angle Therapeutics. Dr. Johnson has stock in Juvena Therapeutics. Dr. Johnson has stock in Evolyra Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. The institution of Dr. Johnson has received research support from Avidity Biosciences. The institution of Dr. Johnson has received research support from Edgewise. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Nicolas Madigan, MD	Dr. Madigan has nothing to disclose.
Irfan A. Shah, MD	No disclosure on file
Seemant Chaturvedi, MD, FAHA, FAAN	Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Mushtaq A. Wani, MD	No disclosure on file
Bisena Bulica, DO	No disclosure on file
Jacques M. Reynolds, DO	No disclosure on file
Joan Holman, MD	No disclosure on file
Jan Kristoper P. De Guzman, MD	No disclosure on file
Ho-seong Han	Ho-seong Han has nothing to disclose.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Robert H. Gross, MD, FAAN	Dr. Gross has nothing to disclose.
Michael R. Wilson, MD, FAAN	Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ouro Medicines. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Indapta Therapeutics. Dr. Wilson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cambridge Medical Experts. Dr. Wilson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dunham Hallmark. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. The institution of Dr. Wilson has received research support from Chan Zuckerberg Initiative. The institution of Dr. Wilson has received research support from Kyverna Therapeutics. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice.
Vanda Lennon, MD, PhD	The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Helio Afonso G. Teive, MD, PhD, FAAN	Dr. Teive has nothing to disclose.
M O. Abdulghani, MD	No disclosure on file
Charles S. Venuto, MD	No disclosure on file
Justin Abbatemarco, MD	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Amgen.
Cecilia Kelly, MD	No disclosure on file
Pervin Iseri, PhD	No disclosure on file
Michelle Fabian, MD, FAAN	Dr. Fabian has nothing to disclose.
Marc Debouverie, MD	Dr. Debouverie has nothing to disclose.
James Noto, DO	No disclosure on file
Tamara Goodman, MD	No disclosure on file
Nathane B. Rezende, MD	Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Aztrazeneca. Dr. Rezende has received research support from ECTRIMS.
Luca Durelli, MD	No disclosure on file
Pitchaiah Mandava, MD, PhD	Dr. Mandava has nothing to disclose.
Charoskhon Turabova, MD	No disclosure on file
Jared M. Yee, MD	No disclosure on file
Christine Stahl, MD	Dr. Stahl has nothing to disclose.
Mariko Hanson, MD	Ms. Hanson has nothing to disclose.
Michael Hast	Michael Hast has received personal compensation for serving as an employee of Merz Therapeutics.
Elaine C. Wirrell, MD, FAAN	Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Todd D. Levine, MD	Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Cheryl Bushnell, MD, MHS	The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Ramon L. Rodriguez Cruz, MD, FAAN	The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Rodriguez Cruz has received research support from Cerevance. The institution of Dr. Rodriguez Cruz has received research support from Neuraly. The institution of Dr. Rodriguez Cruz has received research support from Amneal. The institution of Dr. Rodriguez Cruz has received research support from Teva. The institution of Dr. Rodriguez Cruz has received research support from Neurocrine. Dr. Rodriguez Cruz has received publishing royalties from a publication relating to health care.
Maria Alejandra Gonzalez Duarte, MD, FAAN	Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.
Aimee Borazanci, MD	No disclosure on file
James F. Rini, MD	Dr. Rini has a non-compensated relationship as a Member on Advisory Board with Lilly that is relevant to AAN interests or activities. Dr. Rini has a non-compensated relationship as a Member on Advisory Board with CND Lifesciences that is relevant to AAN interests or activities.
Hamza T. Malek, MD	No disclosure on file
Yan Hou, PhD, MB	Dr. Hou has nothing to disclose.
Mehila Z. Wuhib, MD	No disclosure on file
David P. Vaughan, MBBS	No disclosure on file
Hideki Hirabayashi	No disclosure on file
Brandon Brown	No disclosure on file
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Steven Frucht, MD	Dr. Frucht has nothing to disclose.
Susanne Muehlschlegel, MD, MPH, FAAN	Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grace Pharmaceuticals Inc.. Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Pharmaceuticals Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from Johns Hopkins Stimulating and Advancing Anesthesiology & Critical Care Medicine Research (StAAR) Award. The institution of Dr. Muehlschlegel has received research support from Trustees of The Patrick and Catherine Weldon Donaghue Medical Research Foundation. The institution of Dr. Muehlschlegel has received research support from Harkin Family Fund (Johns Hopkins Dept. of Neurology). Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Speaker and Author with ��ɫ��. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Muehlschlegel has a non-compensated relationship as a Officer of the Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Rachel J. Saunders-Pullman, MD	The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Stuart D. Cook, MD, FAAN	No disclosure on file
Carole Dufouil, PhD	No disclosure on file
Allison Brashear, MD, MBA, FAAN	Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions- start up . Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a Special government employee and study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC.
Irene Cortese, MD	Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC*line Pharma.
Christopher Coffey, PhD, FAAN	Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation.
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Daniel H. Lachance, MD, FAAN	Dr. Lachance has nothing to disclose.
Mario Di Napoli, MD	Dr. Di Napoli has nothing to disclose.
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Joshua P. Klein, MD, PhD, FANA, FAAN	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer Publishers. Dr. Klein has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for various law firms. Dr. Klein has received publishing royalties from a publication relating to health care.
Marie F. Grill, MD	Dr. Grill has nothing to disclose.
Adam Kelly, MD, FAAN	Dr. Kelly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grand Rounds/Included Health. Dr. Kelly has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Kelly has received personal compensation in the range of $500-$4,999 for serving as a Question writer for various educational offerings with ��ɫ��.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Christopher H. Hawkes, MD, Bsc, FRCP, FAAN	Dr. Hawkes has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Sishir Mannava, MD	Dr. Mannava has nothing to disclose.
Oscar H. Del Brutto, MD, FAAN	Dr. Del Brutto has received research support from Universidad Espiritu Santo - Ecuador.
Aurelio Hernandez Lain	No disclosure on file
J. Theodore Phillips, MD, PhD, FAAN	No disclosure on file
Daniel Falcao, DO, FAAN	Dr. Falcao has nothing to disclose.
Lauren L. Spiegel, MD	No disclosure on file
Emily A. Langan, MD	No disclosure on file
Guilherme S. Torezani, MD	Dr. Torezani has nothing to disclose.
Alejandro Thomson, MD	Dr. Thomson has nothing to disclose.
Edward J. Fine, MD, FAAN	Dr. Fine has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Friends of PALS (People with ALS.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Pierre Labauge, MD	Dr. Labauge has nothing to disclose.
Marinella Clerico, MD	Dr. Clerico has nothing to disclose.
Regine Reimers, MD	No disclosure on file
Hazem M. Shoirah, MD	Dr. Shoirah has nothing to disclose.
Sanjay N. Rakhade, MBBS, PhD	Dr. Rakhade has received personal compensation for serving as an employee of Alexion Pharmaceuticals . Dr. Rakhade has stock in Alexion Pharmaceuticals. Dr. Rakhade has stock in Astra Zeneca. Dr. Rakhade has received intellectual property interests from a discovery or technology relating to health care.
Scott Rewinkel, MD	No disclosure on file
Dena Williams, DO	Dr. Williams has nothing to disclose.
Rami-james K. Assadi, MD	No disclosure on file
Okkes Kuybu, MD	No disclosure on file
Alok Patel, MD	No disclosure on file
Ying Zhang	No disclosure on file
Danny Bega, MD	Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Healthcare. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN / ANA. The institution of Dr. Bega has received research support from Huntington Disease Society of America. The institution of Dr. Bega has received research support from Parkinson Foundation.
Spyridon Papapetropoulos, MD, PhD	Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd.
Cameron D. Crockett, MD	No disclosure on file
Susan C. Conrad, MD	No disclosure on file
Robert J. Rudock II, MD	Dr. Rudock has nothing to disclose.
Ilavarasy Maran, MD	Dr. Maran has nothing to disclose.
Tobias Loddenkemper, MD, FAAN	No disclosure on file
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Steven C. Yang, DO	Dr. Yang has nothing to disclose.
Adrian Hadiono, MD	No disclosure on file
Ravouf P. Asimi, MD	No disclosure on file
Janaki Patel, MD	Dr. Patel has nothing to disclose.
Ajal Dave, MD	No disclosure on file
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Michael Schwarzschild, MD, PhD	The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities.
Patrick Vermersch	Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Hany M. Aref, MD, FAAN	Dr. Aref has nothing to disclose.
Grace G. Cheng, MD, PhD	No disclosure on file
Ghazala Perven, MD	Dr. Perven has nothing to disclose.
Yeva M. Fernandez, MD	No disclosure on file
Joe Verghese, MD, FAAN	Dr. Verghese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms Inc. The institution of Dr. Verghese has received research support from National Institutes of Health.
Tobias Walbert, MD, PhD, FAAN	Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion .
Elizabeth M. Aradine, MD	No disclosure on file
Kush Sharma, MBBS	Dr. Sharma has nothing to disclose.
Mark Willy Mondia	Mark Willy Mondia has nothing to disclose.
Meheroz H. Rabadi, MD, FAAN	Dr. Rabadi has nothing to disclose.
Angelo Quartarone, MD	No disclosure on file
Jonathan Santoro, MD	Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
Fabio F. Martins, MD	No disclosure on file
Denis Smirnov	No disclosure on file
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Pria Anand, MD	Dr. Anand has nothing to disclose.
Jinny Min	No disclosure on file
Jonathan Cahill, MD, FAAN	The institution of Dr. Cahill has received research support from Roche / Genentech. Dr. Cahill has received publishing royalties from a publication relating to health care.
Anastasia Zekeridou, MD, PhD, FAAN	The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Bashir A. Sanaie, DM	No disclosure on file
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Pei S. Liu, MD	No disclosure on file
Michael V. Robers, MD	Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation.
Philippe J. Macedo, MD	No disclosure on file
Beverly B. Baliguas, MD	No disclosure on file
Dileep R. Yavagal, MD, FAAN	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Olaf Stuve, MD, PhD, FAAN	Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Jan-Mendelt Tillema, MD	Dr. Tillema has nothing to disclose.
David Weiner, MD	No disclosure on file
Michael F. Waters, MD, PhD, FAAN	Dr. Waters has nothing to disclose.
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Michel Toledano, MD	Dr. Toledano has nothing to disclose.
Goran Davidovic, MD	No disclosure on file
Na Tosha N. Gatson, MD, PhD, FAAN	Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.
David S. Liebeskind, MD, FAAN	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Paul Matthew D. Pasco, MD	The institution of Dr. Pasco has received research support from PCHRD.
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Joel S. Perlmutter, MD, FAAN	Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for CHDI. Dr. Perlmutter has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Parkinson Study Group. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Cooper and Peterson, LLC . Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Simmons and Simmons LLP . The institution of Dr. Perlmutter has received research support from NIH. The institution of Dr. Perlmutter has received research support from American Parkinson Disease Association (Advanced Research Center at Washington University). The institution of Dr. Perlmutter has received research support from CHDI. The institution of Dr. Perlmutter has received research support from Huntington Disease Society of America. The institution of Dr. Perlmutter has received research support from University of Western Toronto. The institution of Dr. Perlmutter has received research support from Barnes-Jewish Hospital Foundation. The institution of Dr. Perlmutter has received research support from Michael J Fox Foundation. The institution of Dr. Perlmutter has received research support from UCSD. The institution of Dr. Perlmutter has received research support from Paula & Rodger Riney FUnd. The institution of Dr. Perlmutter has received research support from Jo Oertli Fund. The institution of Dr. Perlmutter has received research support from Murphy FUnd. The institution of Dr. Perlmutter has received research support from Fixel Fund. The institution of Dr. Perlmutter has received research support from N Grant WIlliams Fund. The institution of Dr. Perlmutter has received research support from Pohlman Fund. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a lecturer with Boston University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a external advisor with Stanford University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with Beth Israel Hospital. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with U Pennsylvania.
John Legge, MD	No disclosure on file
Young-Chul Choi	Young-Chul Choi has nothing to disclose.
Mariam a. Al Hussona, MB BCh BAO	Dr. Al Hussona has nothing to disclose.
Trevor Moravec, MD	No disclosure on file
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Yann Hyvert, PhD	Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany. An immediate family member of Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany.
Kaushik Gowthaman, Jr., MD	No disclosure on file
Sergio A. Castillo-Torres, MD	No disclosure on file
Misealreem Shaheen	No disclosure on file
Kenichi Tsukita	No disclosure on file
Lindsay M. Malatesta, MD	No disclosure on file
Jordan S. Loeb, DO	Dr. Loeb has nothing to disclose.
Ibrahim Laleka	No disclosure on file
Jaydeep Sharma	No disclosure on file
Katherine D. Mathews, MD, FAAN	Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
David A. Robertson, MD	Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Maria Lukasik, MD, PhD	No disclosure on file
Julius Latorre, MD, FAAN	Dr. Latorre has nothing to disclose.
Hunaid Hasan, MD	No disclosure on file
Meriem K. Bensalem Owen, MD	Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a Principle Investigator (PI) with Xenon. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with UCB. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with NeuroPace.
Anthony C. Rodrigues, MD, PhD	No disclosure on file
Jerome Hanna	No disclosure on file
Satabdi Chakrabarti Pulakanti, DO	Dr. Chakrabarti Pulakanti has nothing to disclose.
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Tariq Hamid, MD	Dr. Hamid has nothing to disclose.
Robert Davis	No disclosure on file
Edward Y. Zamrini, MD	Dr. Zamrini has received personal compensation for serving as an employee of George Washington University. Dr. Zamrini has received personal compensation for serving as an employee of Irvine Clinical Research. Dr. Zamrini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Zamrini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Zamrini has received research support from NIH. The institution of Dr. Zamrini has received research support from NIH.
Slawomir Michalak, PhD	No disclosure on file
Pedro A. Kowacs, MD, FAAN	Dr. Kowacs has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Valerie E. Wojna, MD, FAAN	Dr. Wojna has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Puerto Rico Health Sciences Journal, University of Puerto Rico Medical Sciences Campus. The institution of Dr. Wojna has received research support from NIH.
Mark-Victor Siwoski, MD	No disclosure on file
Robert Kadish, MD	Dr. Kadish has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Kadish has received research support from Alexion Pharmaceuticals.
Joy Z. Ding, MD	No disclosure on file
Mallory Smith, NP	No disclosure on file
Ali Kerro, MD	No disclosure on file
Maria Palmeri	Ms. Palmeri has nothing to disclose.
A-Hyun Cho, MD, PhD	No disclosure on file
Paula R. Clemens, MD	The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA.
Letizia Mazzini	No disclosure on file
Sarah Song, MD, MPH, FAAN	Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN.
Sergiusz Jozwiak	No disclosure on file
Raphael A. Carandang, MD, FAAN	Dr. Carandang has nothing to disclose.
Reza Bavarsad Shahripour, MD	Dr. Bavarsad Shahripour has nothing to disclose.
Marcey L. Osgood, DO	Dr. Osgood has nothing to disclose.
Ivana Vodopivec, MD	Dr. Vodopivec has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Vodopivec has received personal compensation for serving as an employee of Novartis. Dr. Vodopivec has stock in Roche.
Sara Dawit, MD	Dr. Dawit has nothing to disclose.
Yasushi Suzuki, MD, PhD	Yasushi Suzuki, MD, PhD has nothing to disclose.
Joseph DeRisi, PhD	Joseph DeRisi, PhD has received personal compensation for serving as an employee of Chan Zuckerberg Biohub. Joseph DeRisi, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allen & Co. Joseph DeRisi, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Public Health Company, Inc. Joseph DeRisi, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Delve Bio. Joseph DeRisi, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for VeriPhi Inc. The institution of Joseph DeRisi, PhD has received research support from Chan Zuckerberg Biohub. Joseph DeRisi, PhD has received intellectual property interests from a discovery or technology relating to health care.
David W. Loring, PhD, FAAN	Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care.
Peter Rieckmann, MD, FAAN	No disclosure on file
Fernanda Herculano, MD	Dr. Herculano has nothing to disclose.
Asad Ikram, MD, MBBS	Dr. Ikram has nothing to disclose.
Carolina Temple	No disclosure on file
Alay Parikh	No disclosure on file
Christopher Lock, MD, MBBS, PhD	Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lock has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Turning Point Litigation. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Goodell, DeVries, Leech & Dann, LLP. Dr. Lock has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McQuaide Blasko Attorneys at Law. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for BENNETT BIGELOW & LEEDOM P.S. .
Andrew C. Young, MD	No disclosure on file
Bregenet Lamour	No disclosure on file
Anne-Louise Meyer, MD	No disclosure on file
Aaron L. Berkowitz, MD, PhD, FAAN	Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill ��ɫ��. Dr. Berkowitz has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Clinical problem Solvers. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Thieme Publisher.
Joel R. Nunez Gonzalez, MD	Dr. Nunez Gonzalez has nothing to disclose.
Inder Puri, MD, MBBS	Dr. Puri has nothing to disclose.
Elizabeth Brigham	No disclosure on file
Akio Kimura, MD	Dr. Kimura has nothing to disclose.
Brunhilde Wirth, PhD	The institution of Prof. Wirth has received research support from Deutsche Forschungsgemeinschaft. The institution of Prof. Wirth has received research support from European Commission.
Jordan Weiss	No disclosure on file
Cathy Chognot	No disclosure on file
Tobias Moser	Mr. Moser has nothing to disclose.
Laurent Vernillet	No disclosure on file
Sabrina Kalam, BM	No disclosure on file
Jayantee Kalita, MD	No disclosure on file
Ylmar Correa Neto, MD	No disclosure on file
Kallol R. Chaudhuri, MD, FRCP	Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.
Doriana Landi	Doriana Landi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Doriana Landi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Doriana Landi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Italia. Doriana Landi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Doriana Landi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Italia. Doriana Landi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Teva. The institution of Doriana Landi has received research support from Italian Ministry of Health.
Aaron M. Carlson, MD	Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Gilles Defer, MD	Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Moira Kapral, MD	The institution of Moira Kapral, MD has received research support from Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research.
Deanna Saylor, MD, MHS	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from ��ɫ��. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and ��ɫ��al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Catherine Legault, MD	No disclosure on file
Devangi S. Mehta, PhD	No disclosure on file
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Thomas J. Shoemaker, MD	Dr. Shoemaker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Shoemaker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AMGEN. Dr. Shoemaker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono.
John Corboy, MD, FAAN	Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Lyell K. Jones, MD, FAAN	Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with ��ɫ��. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Neel N. Patel	No disclosure on file
Zoya Zaeem, MD	Dr. Zaeem has nothing to disclose.
Rima Dafer, MD	Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.
Paul F. Pasquina, MD	No disclosure on file
Vineet Punia, MD	Dr. Punia has nothing to disclose.
Francis M. Gengo, PharmD	No disclosure on file
Karylsa L. Torres Gomez, MD	No disclosure on file
Jaysingh Singh, MD	Dr. Singh has nothing to disclose.
Talal Aboud, MD	No disclosure on file
Simon Thebault, MD	Dr. Thebault has nothing to disclose.
Rashi K. Krishnan, MD	No disclosure on file
Harish Jayakumar, MD MRCP DM DNB FRCP FEBN PDF, FAAN	No disclosure on file
Daniela Andriuta	No disclosure on file
Emmanuel Mignot, MD, PhD	Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa .
James M. Gilchrist, MD, FAAN	Dr. Gilchrist has received publishing royalties from a publication relating to health care.
Nils Henninger, MD, PhD, FANA, FWSO	Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics.
Marian L. Evatt, MD, FAAN	No disclosure on file
Francois Tison, MD, PhD	No disclosure on file
Pravin George, DO	Dr. George has nothing to disclose.
Gabriele Mora, MD	Dr. Mora has nothing to disclose.
Yunxia Wang, MD, FAAN	Dr. Wang has nothing to disclose.
Sankar P. Gorthi, MD, FAAN	Dr. Gorthi has nothing to disclose.
Krunal Shah	No disclosure on file
Mary R. Rensel, MD, FAAN	Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech . The institution of Dr. Rensel has received research support from Biogen.
Shumaila Sultan, MD, FAAN	Dr. Sultan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Eric S. Farbman, MD, FAAN	Dr. Farbman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Farbman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Farbman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda.
Florence Pasquier, MD	Dr. Pasquier has nothing to disclose.
Brigitte Wildemann, MD	The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand.
Deborah Raymond	The institution of Ms. Raymond has received research support from NIH.
Mirela Cerghet, MD, PhD, FAAN	Dr. Cerghet has nothing to disclose.
Raquel Fonseca, MD	No disclosure on file
Andrew J. Zhang, MD	Dr. Zhang has nothing to disclose.
Angelo Antonini, MD	Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Diego Wedemann, MD	No disclosure on file
Christian Bsteh	No disclosure on file
Marco Passini	No disclosure on file
Teryn Nogles, MD	Dr. Nogles has nothing to disclose.
Maggie Savage	No disclosure on file
Melissa J. Nirenberg, MD, PhD, FAAN	The institution of Dr. Nirenberg has received research support from Department of Veterans Affairs,. The institution of Dr. Nirenberg has received research support from National Institutes of Health. Dr. Nirenberg has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with Parkinson's Foundation.
Leopold Saltuari	No disclosure on file
Talyta Grippe, MD	Dr. Grippe has nothing to disclose.
Rajasumi Rajalingam	No disclosure on file
Norberto Cabral	No disclosure on file
Mohamed Fahmy Doheim	Mr. Doheim has nothing to disclose.
Parminder Vig, PhD	No disclosure on file
Mamta B. Singh, MD, MBBS, DM, FAAN	Dr. Singh has nothing to disclose.
Kathleen McKee, MD	Dr. McKee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis.
Doyle Yuan, MD	Dr. Yuan has nothing to disclose.
Michelle Rainka, PharmD	Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
Luis Cunha, PhD	No disclosure on file
Chantale O. Branson, MD, MSCR, FAAN	Dr. Branson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Branson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Padma V. Hadakasira, MD	Dr. Hadakasira has nothing to disclose.
Bruno E. Vidal, MD	No disclosure on file
Marc Kamin, MD	Dr. Kamin has received personal compensation for serving as an employee of SK LIFE SCIENCE INC.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Bryan A. Bernard, PhD	Dr. Bernard has nothing to disclose.
Petr Hlustik, MD, PhD	The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
Florian Eichler, MD	An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Altaf Saadi, MD, MSc, FAAN	The institution of Dr. Saadi has received research support from ��ɫ��. The institution of Dr. Saadi has received research support from National Science Foundation. The institution of Dr. Saadi has received research support from Russel Sage Foundation. The institution of Dr. Saadi has received research support from National Institute of Health.
Nobuaki Yoshikura, MD, PhD	Dr. Yoshikura has nothing to disclose.
Jorge Campos, MD	No disclosure on file
Charenya Anandan, MD	Dr. Anandan has nothing to disclose.
Rod Foroozan	No disclosure on file
Matthew J. Mandel, MD	Dr. Mandel has received personal compensation for serving as an employee of EMD Serono.
Dulanji Kuruppu, MD	Dr. Kuruppu has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Kuruppu has received stock or an ownership interest from Eli Lilly and Company.
Seong-il Oh	No disclosure on file
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
John Y. Fang, MD	No disclosure on file
Pinky H. Agarwal, MD, FAAN	Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharmaceuticals. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AskBio. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vertex Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Vyne Therapeutics. An immediate family member of Dr. Agarwal has stock in Reviva Pharmaceuticals Hld. An immediate family member of Dr. Agarwal has stock in Immuneering Corp. An immediate family member of Dr. Agarwal has stock in Imunon Inc. An immediate family member of Dr. Agarwal has stock in Enlivex Therapeutics. An immediate family member of Dr. Agarwal has stock in Candel Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Digital Corp. An immediate family member of Dr. Agarwal has stock in Atai Life Sciences. An immediate family member of Dr. Agarwal has stock in Adma Biologics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Inhibikase. The institution of Dr. Agarwal has received research support from Intracellular therapeurtics.
Michael Guger	Michael Guger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Michael Guger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Michael Guger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Michael Guger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Michael Guger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Michael Guger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis.
Peter Wipfler	Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Tatsuki Koike	No disclosure on file
Jeffrey L. Elliott, MD	No disclosure on file
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Reena Gottesman, MD	Dr. Gottesman has nothing to disclose.
Clifford Bechtold	No disclosure on file
Tracey H. Fan, DO	Dr. Fan has nothing to disclose.
Luke Chung	Luke Chung has received personal compensation for serving as an employee of Sanofi Genzyme. Luke Chung has received stock or an ownership interest from Sanofi Genzyme.
Dong-Ick Shin, MD, PhD	Dong-Ick Shin, MD, PhD has nothing to disclose.
Sen Sheng, MD	Dr. Sheng has nothing to disclose.
Yukio Kimura	No disclosure on file
Lars Bergmann, MD	Lars Bergmann has received personal compensation for serving as an employee of Abbvie. Lars Bergmann has stock in Abbvie.
Peter Sguigna, MD	Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Sguigna has received research support from Genentech. The institution of Dr. Sguigna has received research support from Clene Nanomedicine. The institution of Dr. Sguigna has received research support from The International Progressive Multiple Sclerosis Alliance through the National Multiple Sclerosis Society. The institution of Dr. Sguigna has received research support from PCORI. The institution of Dr. Sguigna has received research support from DOD/CDMRP. The institution of Dr. Sguigna has received research support from Alexion. Dr. Sguigna has received intellectual property interests from a discovery or technology relating to health care.
Ricardo Varela, MD	No disclosure on file
Diane M. Jacobs, PhD	No disclosure on file
Luis D. Medina, PhD	The institution of Dr. Medina has received research support from National Institutes of Health. Dr. Medina has received personal compensation in the range of $500-$4,999 for serving as a Speaker with AbbVie. Dr. Medina has a non-compensated relationship as a Council Member with Alzheimer's Association that is relevant to AAN interests or activities.
Jorge Zamudio, MD, MBA	Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received stock or an ownership interest from Abbvie .
Gretchen E. Tietjen, MD	An immediate family member of Dr. Tietjen has stock in Johnson & Johnson.
Melissa Armstrong, MD, MSc, FAAN, FAAN	The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Lawrence P. Goldstick, MD	Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for genentech. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi Aventis genzyme. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for emd serono. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TGA therapeutics. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for emd serono. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis genzyme. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers Squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TGA therapeutics. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for bristol meyers squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for genentech. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi aventis genzyme. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for emd serono. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TGA therapeutics. The institution of Dr. Goldstick has received research support from biogen. The institution of Dr. Goldstick has received research support from lily. The institution of Dr. Goldstick has received research support from sanofi Aventis genzyme. The institution of Dr. Goldstick has received research support from genetech.
Christa B. Swisher, MD	Dr. Swisher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Christopher Benjamin, PhD	No disclosure on file
Alyssa Smith, MD	No disclosure on file
Noriko Sato	No disclosure on file
Denahin Hinnoutondji Toffa, MD, PhD, CSCN	Dr. Toffa has nothing to disclose.
Criscely Go, MD	Dr. Go has nothing to disclose.
Sabina Gesell	No disclosure on file
Jihene B. Sassi	Ms. Sassi has nothing to disclose.
Mudasir Mushtaq Shah, MD	Dr. Mushtaq has nothing to disclose.
Bahar S. Malakouti, MD	No disclosure on file
Mayra Montalvo Perero, MD	Dr. Montalvo Perero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG THERAPEUTICS. Dr. Montalvo Perero has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN.
Joao Marcos C. Ferreira, Sr., MD	No disclosure on file
Nurose Karim, MD	Dr. Karim has nothing to disclose.
Shaun Ajinkya, MD	No disclosure on file
Yen-chung Chen, MD	No disclosure on file
Masakazu Nakamura, MD, PhD	No disclosure on file
Danette C. Taylor, DO	No disclosure on file
Ellen Carl, MS	No disclosure on file
Becky J. Parks, MD	Dr. Parks has received personal compensation for serving as an employee of Alexion Pharmaceuticals. An immediate family member of Dr. Parks has received personal compensation for serving as an employee of Edward P. Evans Foundation. Dr. Parks has stock in Biogen. An immediate family member of Dr. Parks has stock in Regeneron. Dr. Parks has stock in Blueprint Medicines. Dr. Parks has stock in Sanofi. An immediate family member of Dr. Parks has stock in Vertex. Dr. Parks has stock in AstraZeneca. The institution of an immediate family member of Dr. Parks has received research support from NIH/NCI. The institution of an immediate family member of Dr. Parks has received research support from Leukemia & Lymphoma Society. The institution of an immediate family member of Dr. Parks has received research support from AstraZeneca Scholar Award.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
John M. Ringman, MD, FAAN	The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP.
Senda Ajroud-Driss, MD, FAAN	Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
David Baker	No disclosure on file
Kymberly Gyure, MD	No disclosure on file
Rohini Coorg, MD	Dr. Coorg has nothing to disclose.
Kendra R. Cagniart, MD	Dr. Cagniart has nothing to disclose.
Joy B. Parrish	An immediate family member of Ms. Parrish has received personal compensation for serving as an employee of DPK Technology. Ms. Parrish has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National football league. Ms. Parrish has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Hockey League.
Andrew G. Engel, MD, FAAN	The institution of Dr. Engel has received research support from NIH.
Patrice Becker	No disclosure on file
Mark J. Morrow, MD	No disclosure on file
Sebastian F. Ameriso, MD	Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Aisling Ryan, PhD, MB, FRCPI	Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Lucas Alessandro, Sr., MD	Dr. Alessandro has nothing to disclose.
Raffaella Umeton, MD, PhD, MMSc	Dr. Umeton has nothing to disclose.
Jay Salpekar	No disclosure on file
Bianca Santomasso, MD	Dr. Santomasso has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen/Johnson & Johnson. Dr. Santomasso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Santomasso has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kite/Gilead. Dr. Santomasso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for In8bio. Dr. Santomasso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for In8bio. Dr. Santomasso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Pharmaceuticals. Dr. Santomasso has received personal compensation in the range of $500-$4,999 for serving as a Committee Member Activity with National Comprehensive Cancer Network.
Karan K. Topiwala, MBBS	No disclosure on file
Barbara F. Diniz, MD	No disclosure on file
Aravindhan Baheerathan, MBBS	No disclosure on file
Rolando Garza	No disclosure on file
Thomas Oxley, MD	No disclosure on file
Spyridon Chalkias, MD	Dr. Chalkias has received personal compensation for serving as an employee of Biogen.
Karen Smirnakis	No disclosure on file
Laura S. Munoz-Arcos, MD	No disclosure on file
Nayme H. Monfredini	No disclosure on file
H. A. Jinnah, MD, PhD, FAAN	Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Huan G. Huynh, MD	No disclosure on file
Brian Wong, MD	No disclosure on file
Saeed Ansari, MD	Dr. Ansari has nothing to disclose.
Mark J. Fisher, MD	The institution of Dr. Fisher has received research support from NIH.
Jack W. Tsao, MD, DPhil, FAAN	The institution of Dr. Tsao has received research support from NIH. The institution of Dr. Tsao has received research support from US Army. Dr. Tsao has received publishing royalties from a publication relating to health care. Dr. Tsao has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Stephen Hantus, MD	Dr. Hantus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hantus has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Reza Behrouz, DO, PhD, FAAN	No disclosure on file
Peter Bede, MD, PhD	Dr. Bede has nothing to disclose.
Inna I. Vaisleib, MD	No disclosure on file
Kathryn A. Davis, MD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals/Jazz Pharmaceuticals. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UNEEG. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Davis has received research support from Eisai. The institution of Dr. Davis has received research support from Liminal. Dr. Davis has received publishing royalties from a publication relating to health care.
Kimberly Vanover, PhD	No disclosure on file
Horacio Capote, MD	No disclosure on file
Mark Mintz, MD, FAAN	Dr. Mintz has nothing to disclose.
David S. Kushner, MD, FAAN	Dr. Kushner has nothing to disclose.
Sun Ju Chung, MD, PhD, FAAN	Dr. Chung has nothing to disclose.
Bradford B. Thompson, MD	Dr. Thompson has nothing to disclose.
Kisekka A. Musubire, MBBS	Dr. Musubire has nothing to disclose.
Piotr Bzdyra, MD	No disclosure on file
Lucy Tan	No disclosure on file
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Cindy Tsui	No disclosure on file
Natalia S. Cunha, MD	Dr. Cunha has nothing to disclose.
Kathleen J. Sweadner, PhD	The institution of Dr. Sweadner has received research support from Hope for Annabel, AHC Foundation, and CureAHC. The institution of Dr. Sweadner has received research support from the Chan-Zuckerberg Initiative.
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Usha K. Misra, MD, FAAN	No disclosure on file
Clare Bassile	Clare Bassile has nothing to disclose.
Ferdinand Otto, MD, PhD	No disclosure on file
Victoria Singh-Curry	No disclosure on file
David Yousem, MD	No disclosure on file
Joel Stein, MD	Dr. Stein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Stein has received personal compensation in the range of $0-$499 for serving as a Consultant for Dessintey. Dr. Stein has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainQ. The institution of Dr. Stein has received research support from BrainQ. The institution of Dr. Stein has received research support from Microtransponder.
Rana Assouad, MD	No disclosure on file
David G. Standaert, MD, PhD, FAAN	Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Inc. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Pharmacy. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll Biopharma. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for F. Hoffman LaRoche. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance, Inc. Dr. Standaert has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorder Society. The institution of Dr. Standaert has received research support from Abbvie, Inc. The institution of Dr. Standaert has received research support from American Parkinson Disease Association. The institution of Dr. Standaert has received research support from National Institutes of Health. The institution of Dr. Standaert has received research support from F. Hoffman LaRoche. Dr. Standaert has received publishing royalties from a publication relating to health care. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with National Institutes of Health. Dr. Standaert has a non-compensated relationship as a Chair, Scientific Advisory Board with American Parkinson Disease Association that is relevant to AAN interests or activities.
Jack Nguyen	No disclosure on file
Christopher Power, MD	Dr. Power has nothing to disclose.
Toby I. Gropen, MD	Dr. Gropen has nothing to disclose.
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Deborah A. Lee, MD, PhD	No disclosure on file
Michael J. Lyerly, MD, FAAN	Dr. Lyerly has nothing to disclose.
Ludwig Aigner, PhD	No disclosure on file
Tatjana Rundek, MD, PhD	The institution of Dr. Rundek has received research support from NIH.
Yuichi Hayashi	Yuichi Hayashi has nothing to disclose.
Mihael V. Varosanec, MD	Dr. Varosanec has received research support from NIH.
Savary Om	No disclosure on file
Erin Balcom, MD	Dr. Balcom has nothing to disclose.
Victor C. Urrutia, MD	Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving as a Medical Director of CME course with PeerView.
Richard S. Bedlack, MD, PhD, FAAN	Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Guidepoint Global. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for New Biotic. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey Pharma. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Pharma. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe America. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Scicence. Dr. Bedlack has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ALS Association. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adept Field Solutions. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apellis. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Swan. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clarivate. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clean. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CM Group. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corcept. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Healthcare. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maple Health Care. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Association of Managed Care Physicians. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Projects in Knowledge. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shinkei Pharma. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Webb MD/Medscape. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mallinkrodt. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amylyx. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for GenieUS. The institution of Dr. Bedlack has received research support from Cytokinetics. The institution of Dr. Bedlack has received research support from Orion. The institution of Dr. Bedlack has received research support from Ultragenyx. The institution of Dr. Bedlack has received research support from MediciNova. The institution of Dr. Bedlack has received research support from Healey Center. Dr. Bedlack has received publishing royalties from a publication relating to health care.
James J. Sejvar, MD, FAAN	Dr. Sejvar has nothing to disclose.
Tobias B. Kulik, MD, FAAN	Dr. Kulik has nothing to disclose.
Nathalie Derache	Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
Andrew Chan	No disclosure on file
Erica S. Westphal	The institution of Ms. Westphal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for McKesson Coorporation. The institution of Ms. Westphal has received research support from Dent Neurologic Institute.
Kelly Baldwin, MD	Dr. Baldwin has nothing to disclose.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Chrispine Oduor	No disclosure on file
Greta S. Peng, MD	No disclosure on file
Gloria Von Geldern, MD, FAAN	The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Ellen B. Penney, MD	No disclosure on file
Ning Wang	No disclosure on file
Jamie Weiss	No disclosure on file
Saurabh Singhal, MD, MBBS	Dr. Singhal has nothing to disclose.
Donald C. Barr, MD	No disclosure on file
Sarah A. Engkjer, RN	No disclosure on file
Jeffrey C. McClean II, MD, FAAN	Dr. McClean has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with ��ɫ��.
Kenneth M. Heilman, MD, FAAN	Dr. Heilman has received publishing royalties from a publication relating to health care.
Ulrich Bogdahn, MD	No disclosure on file
Heather Koons, MD	Dr. Koons has nothing to disclose.
Shirin Jalini, MD	No disclosure on file
David P. Salmon, PhD	Dr. Salmon has nothing to disclose.
Beste Edguer, MD	No disclosure on file
Alberto Ascherio, MD, PhD	Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .
Marcos C. Lange, MD	No disclosure on file
Deborah H. Hall, MD, PhD, FAAN	Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Helena C. Chui, MD	The institution of Dr. Chui has received research support from National Institute on Aging .
Anthony P. Geraci, MD, FAAN	Dr. Geraci has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Geraci has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Geraci has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Geraci has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Geraci has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Geraci has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Geraci has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion.
Christopher Calder, MD, PhD, FAAN	No disclosure on file
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Gustavo Santo, MD	No disclosure on file
Pedro H. Macedo, Sr., MD	No disclosure on file
Jeppe Buchbjerg, PhD	No disclosure on file
Hyungsuk Lee, MD	No disclosure on file
Sarah Marmol, MD	Dr. Marmol has nothing to disclose.
Eric Libell, MD	Dr. Libell has nothing to disclose.
Marc Weisskopf, PhD	Prof. Weisskopf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kaiser Permanente Research Biobank. The institution of Prof. Weisskopf has received research support from ALS Network. The institution of Prof. Weisskopf has received research support from NIH. The institution of Prof. Weisskopf has received research support from Paralyzed Veterans of America. The institution of Prof. Weisskopf has received research support from CDC/ATSDR. The institution of Prof. Weisskopf has received research support from JPB Foundation.
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Samir Blel, MD	No disclosure on file
Whitney Gervelis, DO	No disclosure on file
Pratheep Kumar S, MD	No disclosure on file
Thais Armangue, MD	Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
Lakshman N. Arcot Jayagopal, MD	Dr. Arcot Jayagopal has nothing to disclose.
Patrick Acuna	Mr. Acuna has nothing to disclose.
Jake Torrison, MD	No disclosure on file
Daiki Takewaki	Daiki Takewaki has nothing to disclose.
Diana X. Bharucha-Goebel, MD	No disclosure on file
Guillaume Mathey	Guillaume Mathey has nothing to disclose.
Sorleen Trevino, MD	Dr. Trevino has nothing to disclose.
Pierre Durozard	No disclosure on file
Eavan M. McGovern, MD	No disclosure on file
Akta Patel, DO	No disclosure on file
Jessica H. Lee	No disclosure on file
Susan Matesanz, MD	Dr. Matesanz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Matesanz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Matesanz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atamyo . The institution of Dr. Matesanz has received research support from Sarepta . The institution of Dr. Matesanz has received research support from Pfizer. The institution of Dr. Matesanz has received research support from Genentech/Roche.
Anvi Gadani, MD	No disclosure on file
John Thompson	John Thompson has nothing to disclose.
Claudio A. Osorio, MD	No disclosure on file
Joshua Stone, MD	No disclosure on file
Muhammad O. Salim Khan, DO	Dr. Salim Khan has nothing to disclose.
Yuri S. Macedo, MD	No disclosure on file
Aleksej Zuzek, PhD	Dr. Zuzek has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Zuzek has stock in AbbVie Inc..
Sirisha Kalari	No disclosure on file
Christina M. Lewis	No disclosure on file
Felipe Ibiapina dos Reis	No disclosure on file
Bryan E. Tsao, MD, FAAN	Dr. Tsao has received publishing royalties from a publication relating to health care.
Win Toe, MD	No disclosure on file
Howard M. Chertkow, MD	The institution of Dr. Chertkow has received research support from Hoffmann-La Roche Limited. The institution of Dr. Chertkow has received research support from Anavex Life Sciences. The institution of Dr. Chertkow has received research support from Alector Co.. The institution of Dr. Chertkow has received research support from Lilly.
Alfonso Fasano, MD, PhD, FAAN	Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Abul K. Shoab, MD, FAAN	Dr. Shoab has nothing to disclose.
Sasmit Sarangi, MD, MBBS	The institution of Dr. Sarangi has received research support from Fore biotherapeutics.
Chad Oh	Chad Oh has nothing to disclose.
Martin Cloutier, MD	No disclosure on file
Kelsey M. Smith, MD	The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Greta Sahakyan, MD	No disclosure on file
Andrea Loggini, MD, MPH MBA	Dr. Loggini has nothing to disclose.
Avi Gadoth, MD	Dr. Gadoth has received intellectual property interests from a discovery or technology relating to health care.
Mostafa Hosen, MD	No disclosure on file
Shambaditya Das, Jr., MD, MBBS	Dr. Das has nothing to disclose.
Desiree Nguyen	No disclosure on file
Ratnavalli Ellajosyula, MD, DM, FAAN	Dr. Ellajosyula has nothing to disclose.
Rachel Forman, MD	Dr. Forman has nothing to disclose.
Rajiv Patni, MD	No disclosure on file
Michael C. Hunter, MD	Dr. Hunter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen.
Ioannis K. Valtis	No disclosure on file
Elizabeth McCuaig	No disclosure on file
Alexander Keenan	Alexander Keenan has received personal compensation for serving as an employee of Janssen Pharmaceuticals. Alexander Keenan has received stock or an ownership interest from Johnson and Johnson.
Warren L. Felton III, MD	Dr. Felton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Felton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Pedro Moreira Filho, PhD	No disclosure on file
Simone Spuler, MD	No disclosure on file
Ali Bozorg, MD	Dr. Bozorg has received personal compensation for serving as an employee of UCB Biosciences. Dr. Bozorg has stock in UCB.
Hemil Gonzalez	Hemil Gonzalez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Polsinelli Law Group. The institution of Hemil Gonzalez has received research support from NIH.
Elizabeth Raynor, MD	No disclosure on file
Sven G. Meuth	Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Teresa V. Corona Vazquez, MD	Dr. Corona Vazquez has received research support from Consejo Nacional de Ciencia y Tecnologia.
Marc Petitclerc, MD	No disclosure on file
Eileen Leary, PhD	Dr. Leary has received personal compensation for serving as an employee of Centessa Pharmaceuticals. Dr. Leary has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Partners Group. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulse Infoframe. Dr. Leary has or had stock in Jazz Pharmaceuticals.Dr. Leary has or had stock in Axsome Therapeutics.Dr. Leary has or had stock in Centessa Pharmaceuticals.
Jacinda B. Sampson, MD, PhD	Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
Lindsay A. Horton, MD	Dr. Horton has nothing to disclose.
Kristin L. Miller, MD	Dr. Miller has nothing to disclose.
Katherine Schwartz, DO	No disclosure on file
Eoin Finegan, MBBS	Dr. Finegan has nothing to disclose.
Rahul Chandak, MBBS	No disclosure on file
Krishnamoorthy Kuppusamy, Jr., MD	No disclosure on file
Dong-Hui Ao	No disclosure on file
Tsubasa Yuki	No disclosure on file
Luis M. Negrao, MD	No disclosure on file
Richard P. Goddeau, Jr., DO	No disclosure on file
Puja Mathur, MD	No disclosure on file
Eric Humphriss	Eric Humphriss has received personal compensation for serving as an employee of Annexon Biosciences. Eric Humphriss has stock in Annexon Biosciences.
Zhiyv Niu, PhD, FACMG	Zhiyv Niu has nothing to disclose.
Kristi Michels	No disclosure on file
James C. Johnston, MD, JD, FAAN	Dr. Johnston has a non-compensated relationship as a Director with Global NeuroCare that is relevant to AAN interests or activities.
Monique M. Breteler, MD, PhD	No disclosure on file
Niall Pender, PhD	No disclosure on file
John T. Slevin, MD, FAAN	Dr. Slevin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Slevin has received research support from Veterans Administration. The institution of Dr. Slevin has received research support from NIH. The institution of Dr. Slevin has received research support from AbbVie. The institution of Dr. Slevin has received research support from NeuroDerm. The institution of Dr. Slevin has received research support from Bukwang-Syneos. The institution of Dr. Slevin has received research support from Takeda.
Myrna R. Rosenfeld, MD, PhD, FAAN	Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. An immediate family member of Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Lamson Dugan & Murray LLP. The institution of an immediate family member of Dr. Rosenfeld has received research support from Sage Therapeutics. The institution of an immediate family member of Dr. Rosenfeld has received research support from Edmond J. Safra Foundation. The institution of an immediate family member of Dr. Rosenfeld has received research support from La Caixa Foundation. The institution of an immediate family member of Dr. Rosenfeld has received research support from Spanish Ministry of Health. The institution of an immediate family member of Dr. Rosenfeld has received research support from Department of Health, Government of Catalunya. Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. Dr. Rosenfeld has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Rosenfeld has received publishing royalties from a publication relating to health care. Dr. Rosenfeld has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Rosenfeld has received publishing royalties from a publication relating to health care.
Daniel Pelletier, MD	Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Florian Deisenhammer, MD	Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Deisenhammer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/Celgene. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Dr. Deisenhammer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celgene. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Deisenhammer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SOBI.
Soma Sahai-Srivastava, MD	No disclosure on file
Yen-Yu Chen, MD	No disclosure on file
Lakshmi N. Ranganathan, MD, PhD, FAAN	Dr. Ranganathan has nothing to disclose.
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Maja Relja, MD	No disclosure on file
Dennis L. Kolson, MD, PhD	The institution of Dr. Kolson has received research support from NIH--R01 research grant.
Mirla L. Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Fang Fang	No disclosure on file
Allen J. Aksamit, Jr., MD, FAAN	Dr. Aksamit has nothing to disclose.
Christopher Skinner, MD, FRCPC	No disclosure on file
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Kalpana Merchant	No disclosure on file
Srinivasa Rao Kundeti	Srinivasa Rao Kundeti has nothing to disclose.
Markus Leitinger	Markus Leitinger has nothing to disclose.
Brent Beson, MD	No disclosure on file
Olivier Godefroy, MD, PhD, FAAN	Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NovoNordisk. Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ELSEVIER.
David M. Ermak, DO	Dr. Ermak has nothing to disclose.
Frederic Blanc	No disclosure on file
Brian Silver, MD, FAAN	Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Mukesh Kumar	No disclosure on file
Mahsa Sadeghi, MD	Dr. Sadeghi has nothing to disclose.
Michael S. Duchowny, MD, FAAN	No disclosure on file
Gunnar Buyse, MD, PhD	No disclosure on file
Wolfgang Leesch, MD	No disclosure on file
David K. Simon, MD, PhD	Dr. Simon has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Bial Biotech. An immediate family member of Dr. Simon has stock in Biogen. The institution of Dr. Simon has received research support from Weston Brain Institute. The institution of Dr. Simon has received research support from NIH. The institution of Dr. Simon has received research support from Neuraly. Dr. Simon has received personal compensation in the range of $5,000-$9,999 for serving as a Steering Committee Member: SPARK clinical study with Biogen. Dr. Simon has received personal compensation in the range of $500-$4,999 for serving as a Steering Committee Member: NILO-PD clinical study with Michael J Fox Foundation.
Meetu Bhogal, MSc	No disclosure on file
Gary Heiman	Gary Heiman has nothing to disclose.
Elizabeth Spurgeon, MD	Dr. Spurgeon has nothing to disclose.
Denise Diniz Carneiro	Denise Diniz Carneiro has nothing to disclose.
Ogechukwu Nwanegwo	No disclosure on file
Karlien Mul	The institution of Karlien Mul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences.
Maria K. Houtchens, MD	Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech. The institution of Dr. Houtchens has received research support from Novartis.
Jennifer A. Pallone, DO	No disclosure on file
Michael M. Yochelson, MD, FAAN	Dr. Yochelson has stock in CVS. Dr. Yochelson has stock in Pfizer. The institution of Dr. Yochelson has received research support from AbbVie.
Archana Shrivastava, MD	No disclosure on file
Murat Gultekin, MD	No disclosure on file
Paul M. Elsbernd, MD	Dr. Elsbernd has nothing to disclose.
Wejdan Balubaid, MBBS	No disclosure on file
Ashley Clayton	Ms. Clayton has nothing to disclose.
Spalmai M. Hemat	No disclosure on file
Azara S. Singh, MBBS	Dr. Singh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Pediatrics. Dr. Singh has a non-compensated relationship as a Associate editor, and director of the residents and fellows board of the Journal of Child Neurology with Journal of Child Neurology that is relevant to AAN interests or activities.
Yuqi Qiu	No disclosure on file
Alex Exuzides	Alex Exuzides has nothing to disclose.
David Meya	David Meya has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes of HEalth.
Clary B. Clish	No disclosure on file
Carlos Bernardo Tauil, MD, FAAN	No disclosure on file
Miguel D'Haeseleer, MD, PhD, FAAN	No disclosure on file
Alex Baeta	Alex Baeta has nothing to disclose.
Vijay Renga, MD	Dr. Renga has nothing to disclose.
Michel C. Shamy, MD	Dr. Shamy has nothing to disclose.
Juan G. Ochoa, MD	Dr. Ochoa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Compumedics. Dr. Ochoa has stock in EEG Care, LLC. An immediate family member of Dr. Ochoa has stock in EEG Care, LLC.
Pablo B. Winckler, MD, PhD	Dr. Winckler has nothing to disclose.
Neepa J. Patel, MD, FAAN	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernius Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
John N. Caviness, MD, FAAN	Dr. Caviness has nothing to disclose.
Lawrence S. Bluth, MD	No disclosure on file
Yee K. Cheng, MD	Dr. Cheng has nothing to disclose.
Maurizio Facheris, MD, MSc	Dr. Facheris has received personal compensation for serving as an employee of Vanqua Bio. Dr. Facheris has stock in Vanqua Bio.
Joan A. Conry, MD	No disclosure on file
Susan Vanmeter, MD	Dr. Vanmeter has received personal compensation for serving as an employee of UCB. Dr. Vanmeter has stock in UCB.
Carmen Paradas Lopez, MD, PhD	No disclosure on file
Nancy B. Isenberg, MD, MPH, FAAN	No disclosure on file
Payam Soltanzadeh, MD, FAAN	The institution of Dr. Soltanzadeh has received research support from Ra Pharma (UCB). The institution of Dr. Soltanzadeh has received research support from Avidity Biosciences.
Bruno Stankoff, MD, PhD	The institution of Bruno Stankoff, MD, PhD has received research support from Roche, Sanofi, Serono . The institution of Bruno Stankoff, MD, PhD has received research support from Novartis.
Helmi L. Lutsep, MD, FAAN	Dr. Lutsep has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lutsep has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Coherex Medical. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/Mayo Cinic. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape Neurology.
Nicholas Metrus, MD	Dr. Metrus has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for dotdash / Verywell Health.
Patricia K. Coyle, MD, FAAN	Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Alan Pestronk, MD, FAAN	The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Walter R. Royal III, MD	No disclosure on file
Aashit K. Shah, MD, FAAN	Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Francisco M. Branco Germiniani, MD	Dr. Branco Germiniani has nothing to disclose.
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Navid Seraji-Bozorgzad, MD	No disclosure on file
Melih Tutuncu, MD	No disclosure on file
Peter Z. Yan, MD, MS	Dr. Yan has nothing to disclose.
Milton Biagioni, MD	No disclosure on file
Lenka Hvizdosova	No disclosure on file
Joshua Tam, MD, PhD	No disclosure on file
Pamela W. Duncan, PhD, FAHA, FAPTA	Dr. Duncan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BrainQ Technologies. Dr. Duncan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Pittsburg Pepper Center. Dr. Duncan has stock in CareDirections. The institution of Dr. Duncan has received research support from PCORI. The institution of Dr. Duncan has received research support from NIA and NINDS. The institution of Dr. Duncan has received research support from AHRQ. Dr. Duncan has received intellectual property interests from a discovery or technology relating to health care.
P. D. Charles, MD, FAAN	Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Ivan Da Silva, MD	Dr. Da Silva has nothing to disclose.
David Hojnacki, MD, FAAN	Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Francesca Ammoscato	No disclosure on file
Mhd R. Alkawadri, MD	Dr. Alkawadri has nothing to disclose.
Shareena A. Rahman, MD	Dr. Rahman has nothing to disclose.
Ahmed Z. Obeidat, MD, PhD	Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/genzyme. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Obeidat has received research support from NIH. The institution of Dr. Obeidat has received research support from NMSS and PCORI. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Speaker with CMSC. Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Board of Trustee Member with National MS Society that is relevant to AAN interests or activities.
Amartyadeb Goswami, MD, FAAN	No disclosure on file
Daniel Woo, MD, FAAN	The institution of Dr. Woo has received research support from NIH.
Laura Marsh, MD	No disclosure on file
Or Kakhlon, PhD	Or Kakhlon, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Golden Heart Flower. Or Kakhlon, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Golden Heart Flower.
Cynthia X. Wang, MD	Dr. Wang has nothing to disclose.
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Jeffrey M. Katz, MD	Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.
Meredith Wicklund, MD, FAAN	The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Caroline Papeix	Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN . Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE . Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Caroline Papeix has received personal compensation in the range of $0-$499 for serving as a Consultant for NOVARTIS .
David Brassat, MD, PhD	No disclosure on file
Luiz Felipe Dantas Pagliarini, Sr., MD	No disclosure on file
Anuraag Kansal	No disclosure on file
Jose Maria Cabrera Maqueda	Mr. Cabrera Maqueda has nothing to disclose.
Christopher P. Kellner, MD	Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. Dr. Kellner has stock in Radical. Dr. Kellner has stock in Reach Neuro. Dr. Kellner has stock in Aurenar. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
Ingrid E. Scheffer, MBBS, PhD, FRACP, AO	Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals, Inc. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Longboard Pharmaceuticals . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bellberry Ltd. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Einstein Visiting Fellowship. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Akumentis. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Biocodex. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Chiesi . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Travel/Conference/Speaker honoraria with Stoke Therapeutics. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Zuellig Pharma Inc.. Dr. Scheffer has a non-compensated relationship as a Trial Investigator with Anavex Life Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerecin that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cereval Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Biohaven Ltd. that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Scientific Advisory Board, Trial investigator with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with EpiMinder Inc that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with ES-Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Bright Minds Biosciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Marinus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neurocrine BioSciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neuren Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Praxis Precision Medicines that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator, Scientific Advisory Board with Takeda Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Xenon Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Zogenix that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epileptic Disorders that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Progress in Epileptic Disorders series that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with The Lancet Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Australian Academy of Health and Medical Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Royal Society (Australia). that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Shanghai Zhimeng Biopharma that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with SK Life Science that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Supernus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with UCB Biopharma SRL that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Ultragenyx that is relevant to AAN interests or activities.
Bhupendra O. Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen.
Alfredo Thomson, MD	Dr. Thomson has nothing to disclose.
Francisco Sales, MD	No disclosure on file
Victor J. Del Brutto, MD	The institution of Dr. Del Brutto has received research support from Florida Health Department. The institution of Dr. Del Brutto has received research support from american heart association.
Camila Pupe, MD	Dr. Pupe has nothing to disclose.
John Osborne	No disclosure on file
Valory Pavlik, PhD	The institution of Dr. Pavlik has received research support from Alzheimer's Association.
Margaret S. Lee, PhD	No disclosure on file
Bianca C. Madeira, MD	No disclosure on file
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Roberto Prado, MD, PhD	No disclosure on file
Jonas Saute, MD	No disclosure on file
Melissa Cook, MD	Dr. Cook has nothing to disclose.
Bryan Ceronie, MBBS	Dr. Ceronie has nothing to disclose.
Anne Lodge	No disclosure on file
Eric J. Sorenson, MD, FAAN	The institution of Dr. Sorenson has received research support from Biogen.
Richard D. Serano, MD	No disclosure on file
Harlori K. Bains, MD	Dr. Bains has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Gary A. Stobbe, MD	No disclosure on file
David H. Margolin, MD, PhD	Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Jorge D. Correale, MD	Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Brenda L. Wong, MD	No disclosure on file
Aurelie Ruet	The institution of Aurelie Ruet has received research support from BIOGEN. The institution of Aurelie Ruet has received research support from ROCHE. The institution of Aurelie Ruet has received research support from SANOFI GENZYME. The institution of Aurelie Ruet has received research support from BMS. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Horizon therapeutic. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Alexion. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with BIOGEN. Aurelie Ruet has received personal compensation in the range of $500-$4,999 for serving as a Speaker meeting with MERCK. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with Sanofi Genzyme.
Anton Vladic, MD	No disclosure on file
Pascal Maisonobe	Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
Clarisse Carra-Dalliere	No disclosure on file
Sandra D. Cassard, ScD	No disclosure on file
Tina Duong	Tina Duong has received personal compensation for serving as an employee of Roche. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Scholar Rock. Tina Duong has received personal compensation for serving as an employee of Genentech. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Sarepta. Tina Duong has received personal compensation for serving as an employee of Biogen. Tina Duong has received personal compensation for serving as an employee of Audentes. Tina Duong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tina Duong has received personal compensation in the range of $0-$499 for serving as a Consultant for Audentes. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Tina Duong has received research support from biogen. The institution of Tina Duong has received research support from scholar rock.
Ali K. Choucair, MD	No disclosure on file
Erin M. Okazaki, MD	Dr. Okazaki has nothing to disclose.
Anastasie M. Dunn-Pirio, MD	Dr. Dunn-Pirio has nothing to disclose.
Armin Maghsoudlou, MD	Dr. Maghsoudlou has nothing to disclose.
Catherine Veilleux	No disclosure on file
Michael Rezak, MD, PhD	No disclosure on file
Fred A. Lado, MD	Dr. Lado has a non-compensated relationship as a Board Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Lado has a non-compensated relationship as a Officer with National Association of Epilepsy Centers that is relevant to AAN interests or activities.
Mark Versavel, MD, PhD	An immediate family member of Dr. Versavel has received personal compensation for serving as an employee of Cerevel. Dr. Versavel has received personal compensation for serving as an employee of Eliem. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Grunenthal. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Dr. Versavel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aptinyx. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alzheon. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Finch. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maplight. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Praxix. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Confo.
MaryKay A. Pavol, PhD	Dr. Pavol has nothing to disclose.
Stephen R. Conway, MD	No disclosure on file
Kimberly Maginnis	No disclosure on file
Mark S. Freedman, MD, FAAN	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Clotilde Balucani, MD, PhD	Dr. Balucani has nothing to disclose.
Yasmeen Rauf, MBBS	Dr. Rauf has nothing to disclose.
Deepak Arjundas, MD	No disclosure on file
Batool Kirmani, MD, FAAN	No disclosure on file
Beverly Snively	The institution of Beverly Snively has received research support from National Institutes of Health. The institution of Beverly Snively has received research support from Duke Endowment. The institution of Beverly Snively has received research support from Department of Defense. The institution of Beverly Snively has received research support from PCORI.
Shoichi Shimamoto, MD	No disclosure on file
Dheeraj Khurana, MD	Dr. Khurana has nothing to disclose.
Laurie J. Ozelius, PhD	The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Sami Bajwa, MD	No disclosure on file
Aparna Vaddiparti, MD	Dr. Vaddiparti has nothing to disclose.
Megan E. Esch, MD	The institution of Dr. Esch has received research support from PCORI.
Carrie Li, MD	Dr. Li has nothing to disclose.
Natalie Pawlak	No disclosure on file
Kjetil Bjornevik, MD, PhD	The institution of Dr. Bjornevik has received research support from Michael J. Fox Foundation. The institution of Dr. Bjornevik has received research support from National Multiple Sclerosis Society. The institution of Dr. Bjornevik has received research support from Department of Defense.
Devin D. Mackay, MD, FAAN	Dr. Mackay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Optum. Dr. Mackay has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for various law firms.
Gregg G. Blevins, MD, FRCP(C)	Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-roche. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. The institution of Dr. Blevins has received research support from Novartis. Dr. Blevins has received research support from Hoffman La-Roche. The institution of Dr. Blevins has received research support from EMD Serono. Dr. Blevins has received research support from Biogen Idec. The institution of Dr. Blevins has received research support from MS society of Canada. The institution of Dr. Blevins has received research support from Canadian Institutes of Health Research .
Angela Vidal-Jordana, MD, PhD	No disclosure on file
Devon Cohen, MD	No disclosure on file
A A. Leis, MD, FAAN	No disclosure on file
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Asif M. Paker, MD, MPH	Dr. Paker has received personal compensation for serving as an employee of SwanBio Therapeutics.
Padmaja Vittal, MD, MS	Dr. Vittal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie Pharmaceuticals. Dr. Vittal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals .
Raed Joundi, MD, PhD	Dr. Joundi has nothing to disclose.
David Cantu, PhD	Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Ninad Desai, MBBS	Dr. Desai has nothing to disclose.
Wisam Elmalik, MD	No disclosure on file
Ylec M. Cardenas Castillo, MD	Dr. Cardenas Castillo has nothing to disclose.
Yuki Kitazaki	No disclosure on file
Guido D. Vazquez II, PhD	Dr. Vazquez has nothing to disclose.
Paula Hardeman	Ms. Hardeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Ms. Hardeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Guillermo R. Delgado-Garcia, MD, MSc	Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Team Member with Neurology Resident & Fellow Section that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Brain and Life en Espanol that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Neurology Clinical Practice that is relevant to AAN interests or activities.
Farzaneh A. Sorond, MD, PhD	Dr. Sorond has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Sorond has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. The institution of Dr. Sorond has received research support from NIH.
Tony Daniels	Tony Daniels has received personal compensation for serving as an employee of UCB. Tony Daniels has stock in UCB.
Ania Busza, MD, PhD	Dr. Busza has received research support from NIH/NINDS. Dr. Busza has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Isaac E. Silverman, MD	Dr. Silverman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Various Law Firms.
Christian Bocti, MD	Dr. Bocti has nothing to disclose.
Akiko Matsunaga, MD	AKIKO MATSUNAGA, MD has nothing to disclose.
Taqi T. Zafar, MD	No disclosure on file
Audrey Rico Lamy	No disclosure on file
Mario Sousa, MD	Dr. Sousa has nothing to disclose.
John F. Foley, MD, FAAN	The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Lokesh A. Rukmangadachar, MD	Dr. Rukmangadachar has nothing to disclose.
Abhimanyu Mahajan, MD, MHS, FAAN	Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima Therapeutics, Inc.. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Mahajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adaptive Biosciences . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement disorders clinical practice. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Texas Alzheimer's Research And Care Consortium .
Wayne W. Feng, MD, FAAN	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Sarah Hermanson, DNP, ARNP	No disclosure on file
Danielle Larson, MD	Dr. Larson has received personal compensation in the range of $0-$499 for serving as a Consultant for Acadia Pharmaceuticals.
Akshay Deepak, MD	Dr. Deepak has nothing to disclose.
Viviane H. Zetola, MD	Dr. Zetola has nothing to disclose.
Dimos Dimitrios D. Mitsikostas, MD, PhD	The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Leli Lilly. The institution of Dr. Mitsikostas has received research support from Eli Lilly. Dr. Mitsikostas has a non-compensated relationship as a Co-Chair of Headache Panel with EAN that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a President with Hellenic Headache Society that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with J Headache Pain that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with Frontier Neurology that is relevant to AAN interests or activities.
Jeffrey E. Dunn, MD, FAAN	Dr. Dunn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dunn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Dunn has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Progentec Diagnostics. Dr. Dunn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna Therapeutics. Dr. Dunn has received intellectual property interests from a discovery or technology relating to health care.
Stephen A. VanHaerents, MD, FAAN	An immediate family member of Dr. VanHaerents has received personal compensation for serving as an employee of AbbVie. Dr. VanHaerents has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum Group. Dr. VanHaerents has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firm. An immediate family member of Dr. VanHaerents has stock in AbbVie. The institution of Dr. VanHaerents has received research support from NIH.
JS Charleston	No disclosure on file
Omar M. Wazzan, MD	No disclosure on file
Johann Sellner, MD, FAAN	Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Boehringer, Celgene, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion, Biogen, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $0-$499 for serving as a Reviewer with Ethics Committtee.
Wendy E. Kaye, PhD	Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Paul Mehta	Paul Mehta has nothing to disclose.
Varun C. Pulakanti, MD	Dr. Pulakanti has nothing to disclose.
Saman Zafar, MD	Dr. Zafar has nothing to disclose.
Miriam L. Freimer, MD, FAAN	Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. The institution of Dr. Freimer has received research support from Dept of defense. The institution of an immediate family member of Dr. Freimer has received research support from Abcurro. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presentations/teaching with UCB.
Greg Went	No disclosure on file
Howard S. Kirshner, MD, FAAN	No disclosure on file
S H. Subramony, MBBS, FAAN	Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fallonmedica. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fulcrum. The institution of Dr. Subramony has received research support from Reata. The institution of Dr. Subramony has received research support from Retrotope. The institution of Dr. Subramony has received research support from Acceleron. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Pharnext. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from National Ataxia Foundation. The institution of Dr. Subramony has received research support from Friedreich Ataxia Research Alliance. The institution of Dr. Subramony has received research support from Muscular Dystrophy Association. The institution of Dr. Subramony has received research support from Univ of Rochester, MDA. The institution of Dr. Subramony has received research support from Virginia Commonwealth Univ (FDA, Wyck Foundation)). The institution of Dr. Subramony has received research support from Children's Hospital, Philadelphia (FDA). The institution of Dr. Subramony has received research support from Houston Methodist (NIH). The institution of Dr. Subramony has received research support from NIHR01 AR076060-01A1 . The institution of Dr. Subramony has received research support from NIH2R42HD089804-04 . The institution of Dr. Subramony has received research support from NIH R01 AR056973 . The institution of Dr. Subramony has received research support from FSHD Society. The institution of Dr. Subramony has received research support from AAVANTI BIO. The institution of Dr. Subramony has received research support from COHAV FL State Dept of Health. The institution of Dr. Subramony has received research support from Avidity. The institution of Dr. Subramony has received research support from PTC. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from Vertex. The institution of Dr. Subramony has received research support from Arthrex.
Laura Herbelin	No disclosure on file
Wazim Mohamed, MD	Dr. Mohamed has nothing to disclose.
Katy Eichinger, PhD, PT, DPT, NCS	Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TRiNDS. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association. The institution of Dr. Eichinger has received research support from Muscular Dystrophy Association. Dr. Eichinger has received intellectual property interests from a discovery or technology relating to health care.
Ilena George, MD	The institution of Dr. George has received research support from Biogen.
Erin Robertson-Dick	No disclosure on file
Sabrina Kuespert, PhD	No disclosure on file
Mohammed H. Alkuwaiti, MD	No disclosure on file
Youssef Al Said, MBBS	No disclosure on file
Miriam Galvin, PhD	No disclosure on file
Howard Feldman, MD, FAAN	The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Allyx Pharmaceuticals. The institution of Dr. Feldman has received research support from Canadian Institutes of Health Research . Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Royal Society of Canada that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Banner Health that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter, Manuscript Author with University of British Columbia that is relevant to AAN interests or activities.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Per Odin	Per Odin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Britannia. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Convatec. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Manal A. Badawi, MD	Dr. Badawi has nothing to disclose.
Lauren E. Dunn, MD	Dr. Dunn has nothing to disclose.
Tim-Henrik Bruun, PhD	No disclosure on file
Dinesh V. Jillella, MD	Dr. Jillella has nothing to disclose.
Sankar Bandyopadhyay, MD, FAAN	Dr. Bandyopadhyay has nothing to disclose.
Mei Lu, MD	No disclosure on file
Michael Hoffmann, MD, FCP, FAHA, FAAN	No disclosure on file
Syed Rizvi, MD	Dr. Rizvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono Roche Bristol Myers . Dr. Rizvi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Na.
Amir M. Arain, MD, FAAN	Dr. Arain has nothing to disclose.
Madoka Mori-Yoshimura, MD, PhD	Dr. Mori-Yoshimura has nothing to disclose.
Orhan H. Akman, PhD	No disclosure on file
Ana Sofia Morgadinho, MD	No disclosure on file
David M. Simpson, MD, FAAN	Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Sandra Vukusic, MD	The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche.
Daniel Bandari, MD	The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. The institution of Dr. Bandari has received research support from Genentech. The institution of Dr. Bandari has received research support from EMD-Serono.
Alberto Esquenazi, MD	Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz.
Erik V. Burton, MD	Dr. Burton has nothing to disclose.
Pavel Hok, MD	Dr. Hok has nothing to disclose.
Pirouz Piran, MD	No disclosure on file
Pietro Osvaldo Luigi Annovazzi	No disclosure on file
Ming-Li Li	No disclosure on file
Claire Giannesini	No disclosure on file
Richard S. Isaacson, MD, FAAN	Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Douglas Galasko, MD	Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics.
Jerry R. Mendell, MD, FAAN	Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Sarah Hopkins, MD	The institution of Dr. Hopkins has received research support from NIH. The institution of Dr. Hopkins has received research support from CDC.
Tetsuo Ashizawa, MD, FAAN	An immediate family member of Dr. Ashizawa has received personal compensation for serving as an employee of Biopath Holdings. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cadence. Dr. Ashizawa has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. The institution of Dr. Ashizawa has received research support from NIH. The institution of Dr. Ashizawa has received research support from National Ataxia Foundation. The institution of Dr. Ashizawa has received research support from Myotonic Dystrophy Foundation. The institution of Dr. Ashizawa has received research support from Biogen.
Efrain D. Salgado, MD	Dr. Salgado has nothing to disclose.
Laura Nist, MD, FAAN	Dr. Nist has nothing to disclose.
Sean O'Riordan, MD	Dr. O'Riordan has nothing to disclose.
Drini Dobi, MD, PhD	No disclosure on file
Ugur Uygunoglu	Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Ivan Adamec	Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zentiva. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jadran Galenski laboratorij. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Phoenix farmacija.
Alex J. Linn, MD	No disclosure on file
Advait Mahulikar, MD	No disclosure on file
Ali Hejazi, MD, PhD	No disclosure on file
Brian G. Wong, MD	No disclosure on file
Neil R. Holland, MBBS, FAAN	Dr. Holland has nothing to disclose.
Alida F. Griffith, MD	No disclosure on file
Jeffrey Staab, MD, MS	No disclosure on file
Hindi Al Hindi	Hindi Al Hindi has nothing to disclose.
Galen Joe	No disclosure on file
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Thomas Meier, PhD	No disclosure on file
Susan W. Law, DO	Dr. Law has nothing to disclose.
Ashish Pradhan, MD	Dr. Pradhan has received personal compensation for serving as an employee of Genentech. Dr. Pradhan has received stock or an ownership interest from Genetech.
David C. Anderson, MD, FAAN	No disclosure on file
Aparna M. Prabhu, MD	Dr. Prabhu has nothing to disclose.
Shravan Sivakumar, MBBS	Dr. Sivakumar has nothing to disclose.
Carl J. Boland, MD	No disclosure on file
Danielle C. Mendes, Sr., MD	No disclosure on file
Takayoshi Shimohata, MD, FAAN	Dr. Shimohata has nothing to disclose.
Werner Poewe, MD	Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Lucas Kipp, MD	The institution of Dr. Kipp has received research support from Genentech.
Shifang Liu	No disclosure on file
Maria E. Gonzalez Toledo, MD	No disclosure on file
Tyler Koehn, MD	Dr. Koehn has nothing to disclose.
Salman Aljarallah, MD	Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Genzyme.
Kyong Jin Shin, MD	No disclosure on file
Bryan Dobbs	No disclosure on file
Nina Bozinov, MD	Dr. Bozinov has nothing to disclose.
Thomas L. Davis, MD	Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Parkinson Foundation.
Edward J. Cupler, MD, FAAN	Dr. Cupler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Gustavo Saposnik, MD	Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Chad R. Heatwole, MD, FAAN	Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Legal Med. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $0-$499 for serving as a Consultant for Iris. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for New York Central Mutual. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Penn Prop and Gas. The institution of Dr. Heatwole has received research support from Department of Defense. The institution of Dr. Heatwole has received research support from Novartis. The institution of Dr. Heatwole has received research support from MJFF. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from University of Miami. The institution of Dr. Heatwole has received research support from MDA. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care.
Fabio Nascimento, MD	Dr. Nascimento has received publishing royalties from a publication relating to health care.
Saif A. Bushnaq, MD	Dr. Bushnaq has nothing to disclose.
Svetlana Eckert, MD	Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Laurel J. Cherian, MD, FAAN	The institution of Dr. Cherian has received research support from NIH.
Gobind Singh, MBBS	No disclosure on file
Payam Moein, MD	No disclosure on file
Jennifer Perez	No disclosure on file
Anthony R. Frattalone, MD	No disclosure on file
Sandra Thiel	Ms. Thiel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer Healthcare .
Bruno Dubois, MD	No disclosure on file
Shyam Prabhakaran, MD	Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Cristina Moglia	Cristina Moglia has nothing to disclose.
Jon Williams, DO, PhD	Dr. Williams has nothing to disclose.
Nicholas D. Osteraas, MD	Dr. Osteraas has nothing to disclose.
Jenny Lin, MD	Dr. Lin has nothing to disclose.
Daniel Reich, MD, PhD	Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Fabian Sierra Morales, MD	The institution of Dr. Sierra Morales has received research support from Rush Equity office .
Alex D. Rae-Grant, MD, FRCPC, FAAN	Dr. Rae-Grant has received publishing royalties from a publication relating to health care. Dr. Rae-Grant has received publishing royalties from a publication relating to health care.
Majaz Moonis, MD, FAHA, FAAN	Dr. Moonis has nothing to disclose.
Zaeem A. Siddiqi, MD, PhD	Dr. Siddiqi has nothing to disclose.
Corey R. Fehnel, MD, FAAN	Dr. Fehnel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XRHealth. The institution of Dr. Fehnel has received research support from National Institute on Aging .
Shawna M. Cutting, MD, FAAN	The institution of Dr. Cutting has received research support from Genentech.
Lauren Reoma, MD, FAAN	Dr. Reoma has received research support from NIH. Dr. Reoma has a non-compensated relationship as a Vice Chair with AAN Experimental Neurotherapeutics Section that is relevant to AAN interests or activities. Dr. Reoma has a non-compensated relationship as a Federal Employee with NINDS/NIH that is relevant to AAN interests or activities. Dr. Reoma has a non-compensated relationship as a Member with ASENT Program Committee that is relevant to AAN interests or activities.
Andrew D. Smith III, MD	Dr. Smith has nothing to disclose.
Adalia H. Jun-O'Connell, MD, MBA, FAAN	Dr. Jun-O'Connell has received personal compensation in the range of $5,000-$9,999 for serving as a member with Women's Health Initiative.
Joana Moreira	Joana Moreira has received personal compensation for serving as an employee of BIAL.
Virginia Meca Lallana	Virginia Meca Lallana has nothing to disclose.
Collin C. Luk, MD	Dr. Luk has nothing to disclose.
Akanksha Sharma, MD	Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Generation Care Hospice. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curio Science. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDPI. Dr. Sharma has or had stock in Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Novocure. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities.
Lixin Zhou	Lixin Zhou has nothing to disclose.
Abdul Rahman Alchaki, MD	Dr. Alchaki has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Ali Saad, MD, FAAN	Dr. Saad has nothing to disclose.
Hisham G. Elkhider, MD	Dr. Elkhider has nothing to disclose.
Victor H. Patterson, MD	No disclosure on file
Faycal Hentati, MD	No disclosure on file
Humaira Khan, MD	Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Content creator with ��ɫ�� Institute.
F. M. Cutrer, MD	Dr. Cutrer has received publishing royalties from a publication relating to health care.
Fang Ba, MD	Dr. Ba has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. The institution of Dr. Ba has received research support from Social Sciences and Humanities Research Council.
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Anna M. Szekely, MD	No disclosure on file
Richard Salazar, MD, FAAN	No disclosure on file
Indira De Jesus-Alvelo, MD	Dr. De Jesus-Alvelo has nothing to disclose.
Brett M. Kissela, MD, MS, FAAN	The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
Craig G. Campbell, MD	Dr. Campbell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Campbell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid. The institution of Dr. Campbell has received research support from Biogen. The institution of Dr. Campbell has received research support from Genzyme. The institution of Dr. Campbell has received research support from Acceleron, AMO, Biogen, Sarepta, Wave, PTC, Pfizer, Roche.
Marcela Fiol	Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for merck. The institution of Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
Mohammad Alsharabati, MD	No disclosure on file
Barry Byrne	Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rocket Pharma. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association.
Daniel B. Simmons, MD	No disclosure on file
Jovita Balcaitiene	No disclosure on file
Emanuele Ghione, MD	No disclosure on file
Shu-Yang Zhang	No disclosure on file
Trenton J. Tollefson, MD	Dr. Tollefson has nothing to disclose.
John E. Greenlee, MD, FAAN	Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Lucas Bonamico	No disclosure on file
Xiang Fang, MD, PhD, FAAN	Dr. Fang has nothing to disclose.
Sanjeeva R. Onteddu, MD, FAAN	Dr. Onteddu has nothing to disclose.
Kavita Sail, PhD	No disclosure on file
Candice Chapouly, PhD, PharmD	No disclosure on file
Roman Rubio	Roman Rubio has received personal compensation for serving as an employee of Revance.
Subhendu Rath, MBBS	Dr. Rath has nothing to disclose.
Heather Gordish-Dressman	Heather Gordish-Dressman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AGADA Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TRiNDS, LLC. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Statistical reviewer with TREAT-NMD TACT Committee.
Krishna Nalleballe, MD, FAAN	Dr. Nalleballe has nothing to disclose.
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Mena Samaan, MD	No disclosure on file
Dale Wright	No disclosure on file
Peter A. LeWitt, MD	Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Giuseppe Magnani	Giuseppe Magnani has nothing to disclose.
Janet Benesh, BSMT	No disclosure on file
Matthew D. Holtkamp, DO	Dr. Holtkamp has nothing to disclose.
Gabriel Bsteh, MD	Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Ovais Inamullah, MD	Dr. Inamullah has nothing to disclose.
Coral M. Stredny, MD	Dr. Stredny has stock in Proctor and Gamble. The institution of Dr. Stredny has received research support from Pediatric Epilepsy Research Foundation.
Tomoko Okamoto	Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharma G.K.. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical Co., Ltd.. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teijin Pharma Limited.. The institution of Tomoko Okamoto has received research support from Alexion Pharma G.K.. The institution of Tomoko Okamoto has received research support from Sanofi. The institution of Tomoko Okamoto has received research support from Novartis. The institution of Tomoko Okamoto has received research support from UCB Japan Co., Ltd. The institution of Tomoko Okamoto has received research support from Biogen Japan Ltd.. The institution of Tomoko Okamoto has received research support from Chugai Pharmaceutical Co., Ltd.. The institution of Tomoko Okamoto has received research support from Mitsubishi Tanabe Pharma Corporation. Tomoko Okamoto has received intellectual property interests from a discovery or technology relating to health care.
Stephanie P. Dubow, DO	No disclosure on file
Manabu Araki, MD	No disclosure on file
Jose L. Vega, MD, PhD	No disclosure on file
Dariush Dowlatshahi, MD	Dr. Dowlatshahi has nothing to disclose.
Annie L. Hsieh, MD, PhD	An immediate family member of Dr. Hsieh has received personal compensation for serving as an employee of Pfizer.
Sarah F. Wesley, MD, MPH	Dr. Wesley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wesley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wesley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics.
Klaus Schmierer, MD, PhD	Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Annette Wundes, MD, FAAN	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Rebecca O'Dwyer, MD	Dr. O'Dwyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. O'Dwyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Sciences.
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Tarun Girotra, MD	Dr. Girotra has nothing to disclose.
Thamilpavai Natarajan, MD	Dr. Natarajan has nothing to disclose.
Alejandro Kohler	No disclosure on file
Rachelle Herring, MD	No disclosure on file
Soe S. Mar, MD, FAAN	The institution of Dr. Mar has received research support from NIH.
Jessica Zwerling, MD, FAAN	Dr. Zwerling has nothing to disclose.
Carolina Ionete, MD	Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
Woo-kyung Kim, MD	No disclosure on file
Eliza M. Gordon-Lipkin, MD	No disclosure on file
Vincent Truong, MD	Dr. Truong has nothing to disclose.
Hidehiko Okazawa, MD, PhD	No disclosure on file
Jeffrey M. Chavin, MD, FAAN	Dr. Chavin has received personal compensation for serving as an employee of Sanofi. Dr. Chavin has stock in Sanofi.
Alexander Lossos, MD	Dr. Lossos has nothing to disclose.
Masamichi Ikawa	No disclosure on file
Adil Maarouf	Adil Maarouf has nothing to disclose.
Lily Pham, MD	No disclosure on file
Laura F. Parolin, MD	No disclosure on file
Gregory Krauss, MD	Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Goran Rakocevic, MD, FAAN	Dr. Rakocevic has nothing to disclose.
Kate Bushby, MD	Dr. Bushby has nothing to disclose.
Mario Habek, MD	Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Hailong Cheng	No disclosure on file
Eddie Jones, BA	Eddie Jones, BA has nothing to disclose.
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Kamal Shouman, MD	Dr. Shouman has nothing to disclose.
Abdullah Alshammaa, MD	Dr. Alshammaa has nothing to disclose.
Jose Meca Lallana, MD	Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers-Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Meca Lallana has received research support from Merck. The institution of Dr. Meca Lallana has received research support from Novartis. The institution of Dr. Meca Lallana has received research support from Roche. The institution of Dr. Meca Lallana has received research support from Sanofi. The institution of Dr. Meca Lallana has received research support from Biogen.
Jose Danilo B. Diestro, MD	Dr. Diestro has nothing to disclose.
Daniel P. Kurz, MD	An immediate family member of Dr. Kurz has received personal compensation for serving as an employee of Grainger. Dr. Kurz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation for Sarcoidosis Research. An immediate family member of Dr. Kurz has or had stock in Grainger. The institution of Dr. Kurz has received research support from Biogen.
Marc Verin	Mr. Verin has nothing to disclose.
Nidaullah Mian, MD	No disclosure on file
Richard Libman, MD, FAAN	Dr. Libman has nothing to disclose.
Olivier F. Gout, MD	Dr. Gout has nothing to disclose.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Caroline B. Braune, MD	Dr. Braune has nothing to disclose.
Jennifer J. Choi, MD	No disclosure on file
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Heng Nhoung	No disclosure on file
Reema Choudhry, MD	Dr. Butt has nothing to disclose.
Xiaodong Luo	Xiaodong Luo has received personal compensation for serving as an employee of Sanofi. An immediate family member of Xiaodong Luo has received personal compensation for serving as an employee of Beigene. Xiaodong Luo has stock in Sanofi. An immediate family member of Xiaodong Luo has stock in Beigene. An immediate family member of Xiaodong Luo has stock in Johnson and Johnson.
Thomas F. Scott, MD	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Aleksandra Pikula, MD	The institution of Dr. Pikula has received research support from CIHR.
Deepti Vibha, MD	Dr. Vibha has nothing to disclose.
Daniel J. Burdick, MD, FAAN	Dr. Burdick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Praxis Precision Medicines. The institution of Dr. Burdick has received research support from AbbVie. The institution of Dr. Burdick has received research support from Athira. The institution of Dr. Burdick has received research support from Cerevel. The institution of Dr. Burdick has received research support from Merck. The institution of Dr. Burdick has received research support from Neuraly. The institution of Dr. Burdick has received research support from Pharma 2B. The institution of Dr. Burdick has received research support from Jazz Pharmaceuticals. The institution of Dr. Burdick has received research support from Praxis. The institution of Dr. Burdick has received research support from Sage Therapeutics. The institution of Dr. Burdick has received research support from Biogen. The institution of Dr. Burdick has received research support from Cerevance. The institution of Dr. Burdick has received research support from UCB.
Fernando L. Pagan, MD, FAAN	Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Jacob Mandel, MD	Dr. Mandel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SERVIER PHARMACEUTICALS LLC (US). Dr. Mandel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BAYER HEALTHCARE PHARMACEUTICALS (US.
John B. Williamson	No disclosure on file
Harold Koendgen, MD	Dr. Koendgen has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Koendgen has received stock or an ownership interest from F. Hoffmann-La Roche Ltd .
Mohamed Kazamel, MD	Dr. Kazamel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam Pharamceuticals. Dr. Kazamel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea Therapeutics.
Grace Crotty, MD	The institution of Dr. Crotty has received research support from Parkinson's Foundation. The institution of Dr. Crotty has received research support from ��ɫ��.
Morad Nasseri, MD	No disclosure on file
Maria Julieta Russo, MD	Dr. Russo has nothing to disclose.
David R. Boulware, MD, MPH	The institution of David R. Boulware, MD, MPH has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sfunga. David R. Boulware, MD, MPH has received publishing royalties from a publication relating to health care. David R. Boulware, MD, MPH has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
Khalil Husari, MD	The institution of Dr. Husari has received research support from Maryland Innovation Initiative.
Lakshmi Leishangthem, MD, MBBS	Dr. Leishangthem has nothing to disclose.
Nada A. Elsaid	Mrs. Elsaid has nothing to disclose.
Harald Hegen, MD	Dr. Hegen has nothing to disclose.
Bhavesh Trikamji, MD	Dr. Trikamji has nothing to disclose.
Hamidreza Saber, MD	No disclosure on file
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Gabriela Cohen, MD	No disclosure on file
Steven Levine, MD, FAHA	Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Wendy M. King, PT	Ms. King has nothing to disclose.
Philippe Truffinet, MD	Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
Wolfgang Jost	Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbive. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stada. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stada. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial.
Kameshwar Prasad, MD	The institution of Prof. Prasad has received research support from Government of India Departments of Health Research and Biotechnology.
Channa Kolb, MD	No disclosure on file
Pietro Annovazzi	No disclosure on file
Neil Datta, MD	Dr. Datta has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Global. Dr. Datta has received personal compensation in the range of $0-$499 for serving as a Consultant for Spherix Global.
John Liang, MD	Dr. Liang has nothing to disclose.
George W. Culler IV, MD	Dr. Culler has nothing to disclose.
Pierre Branger	Pierre Branger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVARTIS. Pierre Branger has received personal compensation in the range of $0-$499 for serving as a Consultant for BIOGEN. Pierre Branger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Pierre Branger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
Gregory Vurture	No disclosure on file
Mark Keegan, MD, FAAN	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Michael A. Kelly, MD, FAAN	No disclosure on file
Linda C. Wendell, MD, FAAN	Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple.
William T. Hu, MD, PhD, FAAN	Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Hu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. Dr. Hu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis Pharmaceuticals. The institution of Dr. Hu has received research support from NIA. The institution of Dr. Hu has received research support from TMCity Foundation. The institution of Dr. Hu has received research support from Atlanta Family Foundation. The institution of Dr. Hu has received research support from Fujirebio Diagnostics.
Sabrina Paganoni, MD, PhD	Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Sola. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Frequency Therapeutics. The institution of Dr. Paganoni has received research support from Amylyx. The institution of Dr. Paganoni has received research support from Revalesio. The institution of Dr. Paganoni has received research support from Alector. The institution of Dr. Paganoni has received research support from UCB. The institution of Dr. Paganoni has received research support from Biohaven. The institution of Dr. Paganoni has received research support from Clene. The institution of Dr. Paganoni has received research support from Prilenia. The institution of Dr. Paganoni has received research support from Seelos. The institution of Dr. Paganoni has received research support from Calico. The institution of Dr. Paganoni has received research support from Denali. The institution of Dr. Paganoni has received research support from Anelixis. The institution of Dr. Paganoni has received research support from Cytokinetics.
Dobrivoje S. Stokic	No disclosure on file
Atif Zafar, MD	Dr. Zafar has nothing to disclose.
David M. Waitzman, MD	No disclosure on file
Vernice E. Bates, MD	No disclosure on file
Derek T. Soon, MBBS, PhD	Dr. Soon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legal Clinic.
Riddhi Patira, MD	Dr. Patira has nothing to disclose.
Richard M. Trosch, MD, FAAN	Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal . Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine . Dr. Trosch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Maarten G. Lansberg, MD	Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Richard & Connor. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Keating Jones Hughes. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chason, Rosner, Leary & Marshall. Dr. Lansberg has received publishing royalties from a publication relating to health care.
John H. Sladky, MD, FAAN	Dr. Sladky has nothing to disclose.
Kevin Tan, MD, FAAN	Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Kushak Suchdev, MD	Dr. Suchdev has nothing to disclose.
Sridhara S. Yaddanapudi, MD	Dr. Yaddanapudi has nothing to disclose.
Nadege Gilles	Ms. Gilles has nothing to disclose.
Jorg Wissel	No disclosure on file
Catherine Miller	Catherine Miller has received personal compensation for serving as an employee of Biogen. Catherine Miller has received stock or an ownership interest from Biogen.
Ashraf El-Mitwalli, MD	No disclosure on file
Michael Shaw	Mr. Shaw has nothing to disclose.
Camille S. Corre, MD	Dr. Corre has nothing to disclose.
Fernando Dangond, MD, FAAN	Dr. Dangond has received personal compensation in the range of $1,000,000+ for serving as a Head, Global Clinical Development (employee for 12 years) with EMD Serono.
Rohit Bhatia, MD, MBBS, DM	Dr. Bhatia has nothing to disclose.
Lealani M. Acosta, MD, MPH, FAAN	Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Sage, NIH, Bristol Myers Squibb/Fortrea, CND Life Sciences.
Vivay Peter Misra, MD	No disclosure on file
Edward J. Gettings, DO	Dr. Gettings has nothing to disclose.
Jared Cook	No disclosure on file
Elisabeth Maillart	No disclosure on file
Emily R. Grodinsky, MD	No disclosure on file
Jessica Jarnot, MD	No disclosure on file
Syed F. Ali, MD	No disclosure on file
Ursula Boschert Shafaatian	Ursula Boschert has nothing to disclose.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Sven O. Jarius, MD	Dr. Jarius has nothing to disclose.
Russell Butterfield, MD, PhD, BS	Dr. Butterfield has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Butterfield has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Butterfield has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata. The institution of Dr. Butterfield has received research support from NIH. The institution of Dr. Butterfield has received research support from Ionis. The institution of Dr. Butterfield has received research support from CDC.
Wojciech Kozubski	No disclosure on file
Aashrai S. Gudlavalleti, MBBS	Dr. Gudlavalleti has nothing to disclose.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Alejandro R. Marfil-Rivera, MD	Dr. Marfil-Rivera has nothing to disclose.
Tarun Singhal, MD	Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme Sanofi. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana LifeSciences. The institution of Dr. Singhal has received research support from Novartis. The institution of Dr. Singhal has received research support from Department of Defense. The institution of Dr. Singhal has received research support from Foundation for Neurologic Diseases.
Matthew Schindler, MD, PhD	Dr. Schindler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapuetics. Dr. Schindler has received personal compensation in the range of $5,000-$9,999 for serving as a ��ɫ��al Presenter with Annenberg Center.
Nadia B. Ben Ali, PhD	No disclosure on file
Traci Aladeen, PharmD	Dr. Aladeen has nothing to disclose.
Jun Ni	Jun Ni has nothing to disclose.
William F. Schmalstieg, MD	No disclosure on file
Anabela L. Matos	No disclosure on file
Ian Shih, MD	No disclosure on file
Aman Deep, MD	Dr. Deep has nothing to disclose.
J. David Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Tess Fitzpatrick, MD	No disclosure on file
Leon A. Weinstock, MD	Dr. Weinstock has nothing to disclose.
Mehyar Mehrizi, MD, FAAN	Dr. Mehrizi has nothing to disclose.
Takahiro Iizuka, MD	The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd.
Grant Stotts, MD	Dr. Stotts has nothing to disclose.
Christine Holmstedt, DO	The institution of Dr. Holmstedt has received research support from NIH. The institution of Dr. Holmstedt has received research support from Patient-Centered Outcomes Research Institute.
Federico Silva	Federico Silva has nothing to disclose.
Oluwole O. Awosika, MD, MSCR, FAAN	The institution of Dr. Awosika has received research support from NIH.
Eduardo R. Davidovich	Dr. Davidovich has nothing to disclose.
Marianna Spatola, MD, PhD, FAAN	The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation. The institution of Dr. Spatola has received research support from European Research Coucil.
Moses P. Moorthy, MD	No disclosure on file
Sharjeel Panjwani, MD	No disclosure on file
Nicholas E. Peterson	No disclosure on file
Franziska Di Pauli	Franziska Di Pauli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for horizon. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for merck. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Franziska Di Pauli has received research support from Roche.
Monica M. Diaz, MD, MS	The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund.
Danielle N. Thordarson, MD	Dr. Thordarson has nothing to disclose.
Wiley Hall, MD	No disclosure on file
Ned C. Sacktor, MD, FAAN	No disclosure on file
Raymond Reichwein, MD	No disclosure on file
Genya Watanabe	No disclosure on file
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Nicholas S. Potter, MD, PhD	Dr. Potter has nothing to disclose.
Daniel B. Snyder, PhD	No disclosure on file
Lakshmi Warrior, MD, FAAN	Dr. Warrior has nothing to disclose.
Janice Wong, MD	Dr. Wong has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Wong has received personal compensation for serving as an employee of Biogen. Dr. Wong has stock in Biogen. Dr. Wong has stock in Janssen Research & Development.
Eugen Trinka	Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Eugen Trinka has received research support from European Union. Eugen Trinka has received publishing royalties from a publication relating to health care.
Priyank Khandelwal, MD	Dr. Khandelwal has nothing to disclose.
George Lai, MD	No disclosure on file
Sam H. Horng, MD, PhD	The institution of Dr. Horng has received research support from National Institutes of Health . The institution of Dr. Horng has received research support from Jayne and Harvey Beker Foundation .
Prachi T. Parikh, MD	Dr. Parikh has nothing to disclose.
Dustin M. Anderson, MD	No disclosure on file
Eufrosina I. Young, MD	The institution of Dr. Young has received research support from Mitsubishi Tanabe Pharma America.
Julio Dotor Garcia-Soto	JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck, Biogen, Sanofi-Genzyme, Almirall, Teva, UCB, Novartis.
Maryamnaz Zaribaf, MD	No disclosure on file
Stanley L. Cohan, MD, PhD, FAAN	Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb (Celgene). Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Icometrix.
Steven M. Wolf, MD	Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Assertio. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurilis. Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MOnteris . Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus . The institution of Dr. Wolf has received research support from Neuropace. The institution of Dr. Wolf has received research support from Eisai. The institution of Dr. Wolf has received research support from Aguestive. The institution of Dr. Wolf has received research support from Neurilis . The institution of Dr. Wolf has received research support from UCB. The institution of Dr. Wolf has received research support from SKLife . The institution of Dr. Wolf has received research support from Longboard . The institution of Dr. Wolf has received research support from Takeda. The institution of Dr. Wolf has received research support from biohaven. The institution of Dr. Wolf has received research support from Assertio. Dr. Wolf has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolf has received publishing royalties from a publication relating to health care.
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Amer Malik, MD	Dr. Malik has nothing to disclose.
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Michael Sweeney, MD	Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Jonathan R. Galli, MD	Dr. Galli has nothing to disclose.
Muhammad Affan, MD	Dr. Affan has nothing to disclose.
Yash Jalundhwala, PhD	Dr. Jalundhwala has received personal compensation for serving as an employee of AbbVie . An immediate family member of Dr. Jalundhwala has received personal compensation for serving as an employee of AbbVie . Dr. Jalundhwala has received stock or an ownership interest from AbbVie.
Michelle Devine, MD	The institution of an immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of an immediate family member of Dr. Devine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas. An immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. An immediate family member of Dr. Devine has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AAN. An immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AGRIMS. An immediate family member of Dr. Devine has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Advances in Neurology. The institution of an immediate family member of Dr. Devine has received research support from Center of Individualized Medicine, Mayo Clinic.
Bethany Thomas, NP	Ms. Thomas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Bioscience. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Ms. Thomas has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Science. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Bioscience.
James Conners, MD	The institution of Dr. Conners has received research support from nih.
Vishunmurthy S. Hedna, MD	No disclosure on file
William D. Arnold, MD	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
David M. Tworek, MS, MBA	No disclosure on file
Umberto Manera, MD	Dr. Manera has nothing to disclose.
Randy Robinson, PhD	No disclosure on file
Bhaskar Roy, MD, FAAN	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Cristopher Bragg, PhD	No disclosure on file
Daniel Miller, MD	Dr. Miller has nothing to disclose.
Teerin Liewluck, MD, FAAN	Dr. Liewluck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Liewluck has received publishing royalties from a publication relating to health care.
Shana S. Krstevska, MD	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Kathryn R. Wagner, MD, PhD	Dr. Wagner has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Wagner has stock in F. Hoffmann-La Roche.
Nutan Sharma, MD, PhD, FAAN	Dr. Sharma has nothing to disclose.
Aaron L. Boster, MD	Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
Aram Zabeti, MD	Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Zabeti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Zabeti has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Biogen. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Zabeti has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen . Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG.
Nicolas Dubuisson	No disclosure on file
Yu-Ting Chen, MD	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Mohammad J. Humayun, MD	Dr. Humayun has nothing to disclose.
Harald Pruss	Harald Pruss has nothing to disclose.
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Erik P. Pioro, MD, DPhil, FAAN	Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Barry A. Singer, MD	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb (Celgene). Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Vanda. An immediate family member of Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Singer has received research support from Novartis. The institution of Dr. Singer has received research support from Sanofi. The institution of Dr. Singer has received research support from TG Therapeutics. The institution of Dr. Singer has received research support from Bristol Myers Squibb.
Kavit Shah, MD	Dr. Shah has nothing to disclose.
Eugenia Martinez-Hernandez, MD	Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. The institution of Dr. Martinez-Hernandez has received research support from Fundacio La Caixa. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings and speaker honoraria with UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria and attending meetings with Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with CSL Behring.
Guhan Ramamurthy, MD, DM	Dr. Ramamurthy has nothing to disclose.
Sven Schippling	No disclosure on file
Mindl M. Weingarten, PharmD	Dr. Weingarten has received personal compensation for serving as an employee of SK Life Science.
Yuji Takahashi, MD, PhD	The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Byungkwan Hwang, MD, PhD	No disclosure on file
Martin Nevrly, MD	No disclosure on file
Masoud Majed, MD	Dr. Majed has nothing to disclose.
Dejan Jakimovski, MD, PhD	Dr. Jakimovski has nothing to disclose.
Devin E. Prior, MD	No disclosure on file
Pilar Maria Ferraro, PhD	No disclosure on file
Thomas A. Berger, MD	Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Imran H. Quraishi, MD, PhD	The institution of Dr. Quraishi has received research support from NeuroPace. The institution of Dr. Quraishi has received research support from Biogen. The institution of Dr. Quraishi has received research support from Praxis Precision Medicines.
Ifrah Zawar, MD	The institution of Dr. Zawar has received research support from Alzheimer's association. The institution of Dr. Zawar has received research support from American epilepsy society . The institution of Dr. Zawar has received research support from NIH. The institution of Dr. Zawar has received research support from University of Virginia.
Aiga Rakhesh, MD	Dr. Rakhesh has nothing to disclose.
Burcu Zeydan, MD	The institution of Dr. Zeydan has received research support from National Institutes of Health.
Angela Lee	No disclosure on file
Shashank Agarwal, MD, MBBS	Dr. Agarwal has nothing to disclose.
Sarah Madani, MD	No disclosure on file
Sarah Meira Benchaya, MD	No disclosure on file
Zheng-Yu Jin	No disclosure on file
Helena Gama	Helena Gama has received personal compensation for serving as an employee of Bial-Portela & Cª S.A..
Michael Auer	Michael Auer has nothing to disclose.
Mai Vuong, MD	No disclosure on file
Hennan S. Teixeira, MD	Dr. Teixeira has nothing to disclose.
Nitin Agarwal, MBBS	Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc.
Francesc R. Graus, MD	Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care.
Carlo Colosimo, MD	No disclosure on file
Joseph Hentz	No disclosure on file
Stefano F. Cappa, MD	Dr. Cappa has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elservier. The institution of Dr. Cappa has received research support from Italian Minsitry of Health.
Osman Farooq, MD	Dr. Farooq has nothing to disclose.
Jesper Hagemeier	No disclosure on file
Balasubramanian Samivel, MD	Dr. Samivel has nothing to disclose.
Oleg Y. Yerstein, MD	Dr. Yerstein has nothing to disclose.
Vy T. Nguyen	No disclosure on file
Ivan D. Carabenciov, MD	Dr. Carabenciov has nothing to disclose.
Chirantan Banerjee, MD, MPH	Dr. Banerjee has nothing to disclose.
Lei Liu, MD, PhD	Dr. Liu has nothing to disclose.
Alain Z. Lekoubou Looti, MD	Dr. Lekoubou Looti has nothing to disclose.
Francisco Rocha	Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela.
Victoria Fernandez	Victoria Fernandez has nothing to disclose.
Mariano Marrodan, MD	Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
Alex Rovira	Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Lana Zhovtis Ryerson, MD, FAAN	Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Kunio Nakamura, PhD	Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Cigdem Isitan-Alkawadri, MD	Dr. Isitan-Alkawadri has nothing to disclose.
Michael J. Persenaire, MD	Dr. Persenaire has nothing to disclose.
Xiangyi Meng, PhD	Dr. Meng has nothing to disclose.
Josef M. Gutman, MD	Dr. Gutman has nothing to disclose.
Vincent Arnone, MD	Dr. Arnone has nothing to disclose.
Bakhtier Nurmukhamedov, MD	No disclosure on file
Harold H. Morris III, MD, FAAN	No disclosure on file
Imad M. Najm, MD	Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Patricia E. McGoldrick, NP	No disclosure on file
Mirjam Korporal-Kuhnke, MD	Dr. Korporal-Kuhnke has nothing to disclose.
Mathula Thangarajh, MD, PhD, FAAN	Dr. Thangarajh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Thangarajh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NS Pharma.
Alfonso S. Lopez, MD	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech .
Owais Khadem Alsrouji, MD	No disclosure on file
Alberto Cucca, MD	No disclosure on file
Erica H. Parrotta, DO	No disclosure on file
Koray Onuk	Koray Onuk has nothing to disclose.
Julie R. Korenberg, MD	No disclosure on file
Maria E. Molinaro, MD	Ms. Molinaro has nothing to disclose.
Jesus E. Pina-Garza, MD	Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk. Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group/Acadia. Dr. Pina-Garza has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Same as consultant disclosure. Dr. Pina-Garza has received publishing royalties from a publication relating to health care.
Klaus Seppi, MD	Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO . Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Seppi has received research support from MJFF. The institution of Dr. Seppi has received research support from EU. The institution of Dr. Seppi has received research support from FWF Austrian Science Fund,.
Karin E. Olds, MD	Dr. Olds has nothing to disclose.
Chamindra G. Laverty, MD	The institution of Dr. Laverty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta . Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Laverty has received research support from Sarepta. The institution of Dr. Laverty has received research support from Novartis Gene Therapies. The institution of Dr. Laverty has received research support from Italfarmaco. The institution of Dr. Laverty has received research support from Fibrogen. The institution of Dr. Laverty has received research support from Avidity. The institution of Dr. Laverty has received research support from Dyne.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Tao Xie, MD	Dr. Xie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Caremark. Dr. Xie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceutical Ltd. Dr. Xie has received research support from NIH.
Amre Nouh, MD, FAAN	Dr. Nouh has stock in Openwater.
Lindsey R. Neimand, MD	No disclosure on file
Lawrence M. Samkoff, MD, FAAN	Dr. Samkoff has nothing to disclose.
Victor Fung, MD, MBBS, PhD	Dr. Fung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fung has received publishing royalties from a publication relating to health care.
Sebastian Koch, MD	Dr. Koch has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple Legal Matters. Dr. Koch has received stock or an ownership interest from Cerepeutics. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care.
Muhib Khan, MD, FAAN	The institution of Dr. Khan has received research support from Mayo Clinic ��ɫ�� Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
Antonio Canosa	Antonio Canosa has nothing to disclose.
Atul T. Patel	Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IPSEN. Atul T. Patel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel has received research support from Abbvie. The institution of Atul T. Patel has received research support from IPSEN.
Fnu Abhi Pandhi, MD	No disclosure on file
Gamaleldin M. Osman, MD	Dr. Osman has nothing to disclose.
Bryan Smith, MD	Dr. Smith has nothing to disclose.
Zaheerud Cheema, MD	Dr. Cheema has nothing to disclose.
Nancy Song, MD	Dr. Song has nothing to disclose.
Maria F. Ghilardi, MD	No disclosure on file
Luciano De Paola, MD	No disclosure on file
Gustavo A. Suarez-Zambrano, MD	Dr. Suarez-Zambrano has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America.
Melissa A. Carran, MD	Dr. Carran has nothing to disclose.
Alberto Villarejo Galende	Alberto Villarejo Galende has nothing to disclose.
Makoto Yoneda	The institution of Makoto Yoneda has received research support from Cosmic Corporation.
Marinos C. Dalakas, MD, FAAN	Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Elena Pegoraro, MD, PhD	No disclosure on file
Fabian H. Rossi, MD	Dr. Rossi has nothing to disclose.
Rohan Arora, MD	The institution of Dr. Arora has received research support from Bayer.
Estefania Garcia Molina	Estefania Garcia Molina has nothing to disclose.
Yannan Yu, MD	Dr. Yu has nothing to disclose.
Khashayar Dashtipour, MD, PhD	Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acadia. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for kyowa kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal . Dr. Dashtipour has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for kyowa Kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for amneal . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Dashtipour has received research support from Abbvie. The institution of Dr. Dashtipour has received research support from ipsen. The institution of Dr. Dashtipour has received research support from amneal.
Claire E. Carrazco, DO	No disclosure on file
Sabahattin Saip	Sabahattin Saip has nothing to disclose.
Chia-Chun Chiang, MD	Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene Corporation . Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. The institution of Dr. Chiang has received research support from American Heart Association. The institution of Dr. Chiang has received research support from Lundbeck. The institution of Dr. Chiang has received research support from Pfizer.
Arth K. Srivastava, MD	No disclosure on file
Deidre Ammah, MD	No disclosure on file
Melissa Byrne	No disclosure on file
Maria E. Diaz Ortiz, MD, PhD	No disclosure on file
Shan Gao, PhD	No disclosure on file
Richard L. Barbano, MD, PhD, FAAN	Dr. Barbano has received personal compensation for serving as an employee of State of New York/Office of Mental Health. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Barbano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Barbano has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Visual Dx. Dr. Barbano has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for R L Barbano, MD,PhD, PLLC. The institution of Dr. Barbano has received research support from Fox Foundation. The institution of Dr. Barbano has received research support from Dystonia Study Coalition. The institution of Dr. Barbano has received research support from Revance. Dr. Barbano has received intellectual property interests from a discovery or technology relating to health care.
John R. Pollard, MD	No disclosure on file
Bruno Brochet, MD, FEAN	Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Michael Hutchinson, MD	Dr. Hutchinson has nothing to disclose.
Katrina M. Pack, MD	No disclosure on file
Lindsay N. Alfano, PT	Ms. Alfano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ATOM International, Ltd (Amicus Therapeutics, Catabasis, Genethon, Italfarmaco, NS Pharma, Pfizer, PTC Therapeutics). Ms. Alfano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Novartis Gene Therapies. The institution of Ms. Alfano has received research support from Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Audentes Therapeutics/Astellas Gene Therapies. Ms. Alfano has received intellectual property interests from a discovery or technology relating to health care.
Bree D. DiVentura, MBA	No disclosure on file
Claudia Prada	No disclosure on file
Anthony T. Allen II, MD	No disclosure on file
Suma Shah, MD	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Shah has received research support from Biogen. The institution of Dr. Shah has received research support from National MS Society.
Richard A. Bernstein, MD	No disclosure on file
Johanna T. Fifi, MD, FAAN	Dr. Fifi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker, Inc. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serenity. Dr. Fifi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIVI. Dr. Fifi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Fifi has stock in Endostream. Dr. Fifi has stock in Synchron. Dr. Fifi has stock in Imperative Care. Dr. Fifi has stock in Truvic. Dr. Fifi has stock in Bendit. Dr. Fifi has stock in Cerebrotech. Dr. Fifi has stock in Sim&Cure. Dr. Fifi has stock in Q'Apel. The institution of Dr. Fifi has received research support from Viz AI.
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Dana Horakova	Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Jerry Prince	No disclosure on file
Kalyan Yarraguntla, MD	Dr. Yarraguntla has nothing to disclose.
Georgios Manousakis, MD, FAAN	Dr. Manousakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stealth Biotherapeutics. Dr. Manousakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Manousakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Manousakis has received research support from Marzolf foundation.
Qiang J. Zhang, MD	The institution of Dr. Zhang has received research support from NIH/NIA.
Christopher Black	No disclosure on file
Mark B. Skeen, MD, FAAN	Dr. Skeen has received personal compensation for serving as an employee of VeraSci. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD/Serono. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squib. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD/ Serono. The institution of Dr. Skeen has received research support from National MS Society. Dr. Skeen has received personal compensation in the range of $50,000-$99,999 for serving as a Retiree with US Navy.
Nandakumar Narayanan, MD, PhD	Dr. Narayanan has nothing to disclose.
Sophie Drapier, MD	No disclosure on file
Fiona Scott, PhD	No disclosure on file
Yan Zhang, MD	No disclosure on file
Jean Pelletier, MD, PhD	Dr. Pelletier has nothing to disclose.
Linda P. Lowes, PT PhD	The institution of Ms. Lowes has received research support from Sarepta Therapeutics.
Laura M. Scorr, MD	Dr. Scorr has received research support from Dystonia Medical Research Foundation.
Francisco Germiniani	No disclosure on file
Harry Alexopoulos	No disclosure on file
Kanita Beba Abadal, MD	Dr. Beba has nothing to disclose.
Leonardo V. Modenezi, MD	No disclosure on file
Carlos Santiago Claverie, MD	No disclosure on file
Miguel Chuquilin Arista, MD, FAAN	Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item writer with ��ɫ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with ��ɫ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with ��ɫ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item reviewer with National Board of Medical Examiners. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Southeast regional advisory board with Argenx. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Focus group with Alexion. Dr. Chuquilin Arista has received personal compensation in the range of $0-$499 for serving as a Speaker with Periodic Paralysis Association.
Sanskriti Mishra, MD	No disclosure on file
Bertrand Audoin	No disclosure on file
Golshan Fahimi, MD	Dr. Fahimi has nothing to disclose.
Mohammed Kananeh, MD	Dr. Kananeh has nothing to disclose.
Subin Mathew, MD	Dr. Mathew has nothing to disclose.
Daniel D. Truong, MD, FAAN	The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
Thomas Leist, MD, PhD, FAAN	Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Ismail A. Khatri, MD, MBBS, FAAN	Dr. Khatri has nothing to disclose.
Arielle Davis, MD	Dr. Davis has nothing to disclose.
Sumit Verma, MD	Dr. Verma has nothing to disclose.
Gareth R. John	No disclosure on file
Sanam Anwer, MBBS	No disclosure on file
Jenny Siv, MD	No disclosure on file
Conor Ryan, MD	No disclosure on file
Carolina VIVAR, MD	Dr. VIVAR has nothing to disclose.
Michael Rabbia	No disclosure on file
Cheryl Smith, MD	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Smith has received research support from Sanofi. The institution of Dr. Smith has received research support from Alexion. The institution of Dr. Smith has received research support from Susan Dorsch Research Fund.
Ayesha Ahmad, MD	Dr. Ahmad has nothing to disclose.
Daniela A. Pimentel Maldonado, MD, MSCR	Dr. Pimentel Maldonado has nothing to disclose.
Angela M. Hawkins, RN	No disclosure on file
Muhammad Niazi, MD	No disclosure on file
Ahmad Yusuf Solaiman, MD	Dr. Yusuf Solaiman has nothing to disclose.
Fei-Fei Zhai	Fei-Fei Zhai has nothing to disclose.
Maggie C. Walter, MD	No disclosure on file
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
John A. Morren, MD, FAAN	Dr. Morren has received publishing royalties from a publication relating to health care.
Laura Simionescu, MD	Dr. Simionescu has received publishing royalties from a publication relating to health care.
Steve Chung, MD, FAAN	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Catherine Lubetzki	Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK SERONO. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REWIND.
Caroline Bensa	Caroline Bensa has nothing to disclose.
Eleonora Cocco	No disclosure on file
Nirali Vora, MD	Dr. Vora has nothing to disclose.
Keith Van Haren, MD	Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
Nawaz Hack, MD	Dr. Hack has nothing to disclose.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Steven Edland	No disclosure on file
Alison L. Christy, MD, PhD, FAAN	Dr. Christy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity. Dr. Christy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishing. Dr. Christy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDLinx. The institution of Dr. Christy has received research support from Biohaven. The institution of Dr. Christy has received research support from Novartis / Amgen. The institution of Dr. Christy has received research support from Eli Lilly. The institution of Dr. Christy has received research support from Abbvie.
Ester Carreon Guarnizo	Ester Carreon Guarnizo has nothing to disclose.
Alessandro Di Rocco, MD	Dr. Di Rocco has nothing to disclose.
Elena Bravver, MD	No disclosure on file
Carlo Caltagirone	No disclosure on file
J Mocco	No disclosure on file
Joel C. Geerling, MD, PhD	No disclosure on file
Nicholas J. Everage	No disclosure on file
Jibreel Jumare	No disclosure on file
Rezaul Khandker	Rezaul Khandker has received personal compensation for serving as an employee of Merck & Co., Inc.. Rezaul Khandker has stock in Merck & Co., Inc..

��ɫ����

��ɫ����

��ɫ��

��ɫ��